Guidewire feeder

Information

  • Patent Grant
  • 10449333
  • Patent Number
    10,449,333
  • Date Filed
    Thursday, March 13, 2014
    10 years ago
  • Date Issued
    Tuesday, October 22, 2019
    4 years ago
Abstract
Apparatus for use with a guidewire is provided, the apparatus including (1) a first housing, shaped to define a first channel through which the guidewire is slidable; (2) a second housing, shaped to define a second channel through which the guidewire is slidable in at least a first direction toward the first housing; (3) a guidewire-engaging element, disposed within the second housing, and configured to inhibit the guidewire from sliding through the second channel in a second direction away from the first housing; and (4) a tubular member, (a) shaped to define a lumen therethrough, through which the guidewire is slidable, and (b) coupled to the second housing and slidably coupled to the first housing. Other embodiments are also described.
Description
FIELD OF THE INVENTION

Some applications of the invention relate to medical apparatus and techniques. Some applications of the invention relate more specifically to apparatus and techniques for percutaneous medical procedures, such as those involving the use of a guidewire.


BACKGROUND

Percutaneous (e.g., transluminal) medical procedures often require the use of a guidewire to facilitate positioning of percutaneous medical devices (e.g., tools, catheters, implants, etc.). Manipulation of the guidewire, such as feeding the guidewire distally into the body of a subject, is often performed by hand.


SUMMARY OF THE INVENTION

A guidewire feeder is provided, comprising a first housing that defines a first channel therethrough, a second housing that defines a second channel therethrough, and a tubular member that is coupled to the second housing and slidably coupled to the first housing. A guidewire disposed within the first channel, the second channel and the tubular member is moved distally through the feeder by repeatedly moving the second housing toward and away from the first housing such that the tubular member slides into and out of the second housing. Each time the second housing is moved toward the first housing, a portion of the guidewire that is disposed within the tubular member is slid distally, with the tubular member, into the first housing. Each time the second housing is moved away from the first housing, the tubular member slides proximally out of the first housing and over the portion of the guidewire, the guidewire remaining stationary with respect to the first housing. Oscillation of the second housing toward and away from the first housing thereby advances the guidewire through the first channel.


A guidewire-engaging element, coupled to the second housing, is configured to facilitate one-way movement of the guidewire through the second channel, and thereby to facilitate the function of the guidewire feeder described hereinabove. For some applications, an engagement switch is configured to move the guidewire-engaging element between an engaged state in which the guidewire feeder functions as described hereinabove, and a disengaged state in which the guidewire is slidable through the second channel in either direction (e.g., so as to facilitate initial threading of the guidewire through the guidewire feeder).


For some applications, the guidewire feeder is configured to be coupled to a medical device for percutaneous procedures. For some applications the guidewire feeder is used to advance the guidewire distally through the medical device. For some applications, the guidewire feeder is used to facilitate withdrawal of the medical device over the guidewire, while maintaining the position of the guidewire (e.g., a distal end thereof) with respect to the body of the subject.


There is therefore provided, in accordance with an application of the present invention, apparatus for use with a guidewire, the apparatus including:


a first housing, shaped to define a first channel through which the guidewire is slidable;


a second housing, shaped to define a second channel through which the guidewire is slidable in at least a first direction toward the first housing;


a guidewire-engaging element, disposed within the second housing, and configured to inhibit the guidewire from sliding through the second channel in a second direction away from the first housing; and


a tubular member:

    • shaped to define a lumen therethrough, through which the guidewire is slidable, and
    • coupled to the second housing and slidably coupled to the first housing.


In an application, the tubular member is slidable within the first channel.


In an application:


the guidewire-engaging element has an engaged state and a disengaged state, and is configured to inhibit the guidewire from sliding through the second channel in the second direction, only when in the engaged state, and


the apparatus further includes an engagement switch, configured to reversibly move the guidewire-engaging element between the engaged state and the disengaged state.


In an application, the apparatus is configured to facilitate percutaneous advancement of the guidewire by a physician, while the physician (a) directly holds the second housing of the device with only one finger and one thumb, and (b) does not directly hold the first housing.


In an application, the lumen of the tubular member provides communication between the first channel and the second channel.


In an application, the tubular member is more rigid than the guidewire, and is configured to inhibit bending of a portion of the guidewire that is disposed within the lumen of the tubular member.


In an application, the first channel, the second channel, and the lumen are collinear.


In an application, the first channel, the second channel, and the lumen define an axis, and the second housing is rotatable around the axis.


In an application, the tubular member is coupled to the second housing and slidably coupled to the first housing such that the second housing is slidable toward the first housing and away from the first housing.


In an application, the apparatus is configured such that, while a portion of the guidewire is disposed within the second channel, when the second housing is moved toward the first housing, the guidewire moves in the first direction.


In an application, the apparatus is configured such that, while the portion of the guidewire is disposed within the second channel, oscillation of the second housing between the first direction and the second direction moves the guidewire in the first direction.


In an application, the apparatus is configured such that, when the second housing slides toward the first housing, the tubular member slides into the first housing.


In an application, the apparatus is configured such that, while the portion of the guidewire is disposed within the second channel, and a portion of the guidewire is disposed within the lumen of the tubular member, when the second housing is moved toward the first housing, the portion of the guidewire that is disposed within the lumen of the tubular member moves while within the tubular member into the first housing, without moving with respect to the tubular member.


In an application, the apparatus is configured such that, when the second housing slides toward the first housing, the tubular member slides into the first channel.


In an application, the apparatus is further for use with a device for facilitating percutaneous procedures, and the first housing is configured to be coupled to the device.


In an application, the first housing includes a coupling member, configured to facilitate coupling the first housing to the device.


In an application, the coupling member includes a generic coupling member, configured to facilitate coupling of the first housing to any of a range of devices for facilitating percutaneous procedures.


In an application, the coupling member includes a strap.


In an application, the guidewire-engaging element is configured such that, while the guidewire is disposed within the second channel, when the guidewire moves in the second direction, the guidewire-engaging element responsively grips the guidewire.


In an application, the guidewire-engaging element is pivotally coupled to the second housing.


In an application, the guidewire-engaging element defines a guidewire-engaging edge, and is configured such that, while the guidewire is disposed within the second channel, the guidewire-engaging edge is disposed against the guidewire at a nonzero angle, such that movement of the guidewire in the second direction through the second channel causes the guidewire-engaging edge to press into the guidewire.


In an application, the guidewire-engaging element is configured such that, while the guidewire is disposed within the second channel, when the guidewire-engaging edge presses into the guidewire, the nonzero angle becomes closer to a right angle.


In an application, the guidewire-engaging element is configured such that, while the guidewire is disposed within the second channel, the guidewire-engaging edge is disposed against the guidewire at a nonzero angle that is not a right angle.


In an application, the guidewire-engaging edge is configured such that, while the guidewire is disposed within the second channel, the guidewire-engaging edge is disposed against the guidewire at an obtuse angle with respect to a portion of the guidewire that is disposed closer to the tubular member than is the guidewire-engaging edge.


There is further provided, in accordance with an application of the present invention, a method for use with a guidewire, the method including:


providing apparatus including:

    • a first housing,
    • a second housing, and
    • a tubular member, coupled to the second housing and slidably coupled to the first housing;


sliding a portion of the guidewire that is disposed within the tubular member in a first direction through the first housing by sliding the tubular member into the first housing by moving the second housing toward the first housing; and


moving the second housing away from the first housing without sliding the guidewire in a second direction through the first housing.


In an application, the method further includes percutaneously advancing the guidewire by sliding the portion of the guidewire in the first direction.


In an application, moving the second housing toward the first housing includes moving the second housing toward the first housing using only one finger and one thumb.


In an application, sliding the tubular member into the first housing includes sliding, into the first housing, a tubular member that is more rigid than the guidewire and is configured to inhibit bending of the portion of the guidewire.


In an application, the method further includes coupling the first housing to a device for facilitating percutaneous procedures.


In an application, the method further includes coupling the first housing to a body of a subject.


In an application, the apparatus includes a guidewire-engaging element, disposed within the second housing, and having an engaged state and a disengaged state, and the method further includes:


feeding the guidewire into at least the second housing while the guidewire-engaging element is in the disengaged state; and


subsequently moving the guidewire-engaging element into the engaged state.


In an application, moving the guidewire-engaging element into the engaged state includes moving the guidewire-engaging element into the engaged state using an engagement switch, configured to reversibly move the guidewire-engaging element between the engaged state and the disengaged state.


In an application, the apparatus includes a guidewire-engaging element coupled to the second housing, and moving the second housing toward the first housing includes moving the second housing toward the first housing such that the guidewire-engaging element responsively grips the guidewire.


In an application, moving the second housing toward the first housing includes moving the second housing toward the first housing such that the guidewire-engaging element responsively pivots with respect to the second housing.


In an application, the guidewire-engaging element defines a guidewire-engaging edge, and moving the second housing toward the first housing includes moving the second housing toward the first housing such that the guidewire-engaging edge presses into the guidewire.


There is further provided, in accordance with an application of the present invention, a method, including:


moving a distal end of a percutaneous medical device in a proximal direction away from an anatomical site of a body of a subject; and


simultaneously, maintaining a position, with respect to the anatomical site, of a distal end of a guidewire that is slidable through the medical device by moving, toward a first housing that is coupled to the medical device, a second housing.


In an application, moving the distal end of the medical device includes pulling a handle of the medical device in the proximal direction using a first hand, and moving the second housing toward the first housing includes moving the second housing toward the first housing using a second hand.


In an application, moving the distal end of the medical device includes moving the distal end of the medical device at a first speed, and moving the second housing toward the first housing includes moving the second housing toward the first housing at a second speed that is relative to the first speed.


In an application, moving the distal end of the medical device includes moving the distal end of the medical device a first distance, and moving the second housing toward the first housing includes moving the second housing toward the first housing a second distance that is relative to the first distance.


In an application, moving the second housing toward the first housing includes moving the second housing toward the first housing such that a guidewire-engaging element, coupled to the second housing, responsively grips the guidewire.


In an application, moving the second housing toward the first housing includes moving the second housing toward the first housing such that the guidewire-engaging element responsively pivots with respect to the second housing.


In an application, the guidewire-engaging element defines a guidewire-engaging edge, and moving the second housing toward the first housing includes moving the second housing toward the first housing such that the guidewire-engaging edge presses into the guidewire.


In an application, the method further includes sliding at least the second housing over a proximal end of the guidewire and distally along the guidewire, and coupling at least the second housing to the medical device.


In an application, sliding at least the second housing distally along the guidewire includes sliding at least the second housing distally along the guidewire while a guidewire-engaging element, coupled to the second housing, is in a disengaged state thereof, and the method further includes, subsequently to coupling at least the second housing to the medical device and prior to maintaining the position of the distal end of the guidewire, moving the guidewire-engaging element into an engaged state thereof.


In an application, moving the guidewire-engaging element into the engaged state includes moving the guidewire-engaging element into the engaged state using an engagement switch, configured to reversibly move the guidewire-engaging element between the engaged state and the disengaged state.


In an application, moving the second housing toward the first housing includes moving the second housing at least 1 cm toward the first housing.


In an application, moving the second housing toward the first housing includes moving the second housing at least 3 cm toward the first housing.


In an application, moving the second housing toward the first housing includes moving the second housing at least 4 cm toward the first housing.


In an application, moving the second housing toward the first housing includes sliding into the first housing, a tubular member that is coupled to the second housing and slidably coupled to the first housing.


In an application, sliding the tubular member into the first housing includes sliding a portion of the guidewire that is disposed within the tubular member into the first housing without the portion of the guidewire moving with respect to the tubular member.


In an application, sliding the tubular member into the first housing includes sliding, into the first housing, a tubular member that is more rigid than the guidewire and is configured to inhibit bending of the portion of the guidewire.


In an application, the method further includes subsequently sliding the tubular member out of the first housing by moving the second housing away from the first housing, without sliding the guidewire with respect to the first housing.


The present invention will be more fully understood from the following detailed description of embodiments thereof, taken together with the drawings, in which:





BRIEF DESCRIPTION OF THE DRAWINGS


FIGS. 1-2 are schematic illustrations of a guidewire feeder for facilitating handling of a guidewire, in accordance with some applications of the invention;



FIGS. 3A-B and 4A-B are schematic illustrations of a guidewire feeder, in accordance with some applications of the invention;



FIGS. 5A-D are schematic illustrations of a guidewire feeder being used to advance the guidewire, in accordance with some applications of the invention;



FIG. 6 is a schematic illustration of a guidewire feeder being used to advance the guidewire into the femoral vein of a subject, in accordance with some applications of the invention;



FIG. 7 is a schematic illustration of a guidewire feeder, for use with the guidewire and a cannula, in accordance with some applications of the invention; and



FIGS. 8A-B are schematic illustrations of a guidewire feeder being used to facilitate movement of a medical device with respect to at least a portion of a guidewire, in accordance with some applications of the invention.





DETAILED DESCRIPTION OF EMBODIMENTS

Reference is made to FIGS. 1-2, which are schematic illustrations of a guidewire feeder 40 for facilitating handling of a guidewire 42, in accordance with some applications of the invention. FIG. 1 shows a solid view of guidewire feeder 40 coupled to a medical device 41 for facilitating percutaneous (e.g., transluminal) procedures, and FIG. 2 shows an exploded view of the guidewire feeder. Together, guidewire feeder 40 and guidewire 42 define a system 20. It is to be noted that device 41 is shown as a non-limiting illustrative example of a device to which guidewire feeder 40 is couplable.


Feeder 40 comprises a first housing 44, a second housing 46, and a tubular member 48 that is coupled to the second housing and slidably coupled to the first housing. First housing 44 defines a first channel 54 therethrough, second housing 46 defines a second channel 56 therethrough, and tubular member 48 defines a lumen therethrough. Tubular member 48 (e.g., the lumen thereof) typically provides communication between first channel 54 and second channel 56. First channel 54, tubular member 48, and second channel 56 are typically collinear. Further typically, tubular member 48 is slidably coupled to first housing 44 by being slidable within first channel 54. Tubular member 48 is typically fixedly coupled to second housing, such as by a portion of the tubular member being fixedly coupled within a portion of second channel 56. Feeder 40 further comprises a guidewire-engaging element 60 that is coupled to and/or disposed within second housing 46, and is configured to selectively inhibit the guidewire from sliding through the second channel away from the first housing (e.g., and to not inhibit the guidewire from sliding through the second channel toward the first housing).


Guidewire 42 typically fits snugly within channel 54, channel 56 and/or tubular member 48, but not tightly enough to prevent sliding thereof (e.g., such that the guidewire is subject to friction that is not significantly higher than that to which it is subjected within medical device 41). For some applications, inner surfaces of channel 54, channel 56 and/or tubular member 48 are coated with a low-friction coating so as to further reduce inhibition of advancement of the guidewire. For some applications, guidewire 42 itself is subjected to a friction-reducing treatment (e.g., heat-treated and/or coated with a low-friction coating). Guidewire-engaging element 60 is configured to grip guidewire 42 despite this treatment of the guidewire. Indeed, some prior art guidewires are subjected to a friction-reducing treatment, and feeder 40 may be particularly useful in handling such guidewires.


When second housing 46 is moved toward first housing 44, at least a portion of tubular member 48 slides into the first housing. While a portion of guidewire 42 is disposed within feeder 40, when second housing 46 is moved toward first housing 44, a portion of the guidewire that is disposed within tubular member 48 is pushed, along with the tubular member, into the first housing (e.g., into first channel 54). In contrast, when second housing 46 is moved away from first housing 44, although tubular member 48 slides out of the first housing, the guidewire does not follow. Thereby, oscillation of second housing 46 toward and away from first housing 44 (e.g., along a longitudinal axis a1 defined by first channel 54, tubular member 48, and second channel 56; shown in FIGS. 3B and 4B) moves the guidewire in a single direction through the first housing. This is described in more detail with respect to FIGS. 5A-D.


Percutaneous (e.g., transluminal) guidewires are typically flexible and thereby imparting a pushing force on a guidewire results in bending (e.g., kinking or buckling) of a portion of the guidewire that is distal to the point of pushing, e.g., between the point of pushing and a point of resistance, such as an entry point (e.g., to a body of a subject and/or to another medical device). This makes pushing of the guidewire (e.g., distally into the body of the subject) difficult and/or inefficient. In system 20, the point of pushing is at and/or within second housing 46 (e.g., at guidewire-engaging element 60) and, as shown in FIG. 1, first housing 44 is typically reversibly coupled (e.g., reversibly attached) to the other medical device (e.g., medical device 41), such that guidewire 42 is generally not exposed between the first housing and the medical device. Thereby, guidewire feeder 40 provides rigidity (e.g., support) to the aforementioned portion of the guidewire that is disposed between the pushing point and the entry point to the medical device. Furthermore, for applications in which guidewire 42 extends through the medical device, the guidewire is typically generally not exposed between the first housing and a distal portion of the medical device (i.e., a portion of the medical device that is furthest from feeder 40). Still further, guidewire 42 typically fits snugly within second channel 56, tubular member 48, first channel 54, and the medical device (e.g., a lumen defined by the medical device). Thereby, the guidewire, from the first housing to the distal portion of the medical device, is typically inhibited from bending. It is to be noted that throughout this application, including the specification and the claims, such inhibiting of bending refers to undesired bending (e.g., kinking and/or bucking), such as that described earlier in this paragraph as occurring between a point of pushing and a point of resistance, and does not include desired bending such as that caused by confirmation of the guidewire to a particular shape of feeder and/or medical device 41 (e.g., so as to navigate the vasculature of the subject). Guidewire feeder 40 may alternatively be coupled directly to the body of the subject (e.g., as described hereinbelow with reference to FIG. 6).


It is particularly notable that tubular member 48, which is typically more rigid than guidewire 42, provides rigidity to the portion of the guidewire that is disposed between second housing 46 and first housing 44, and thereby inhibits bending of this portion of the guidewire. The rigidity provided by guidewire feeder 40 (e.g., tubular member 48 thereof) typically allows a longer portion of guidewire 42 to be pushed in each ‘stroke’, e.g., compared to pushing the guidewire by hand. For example, each oscillation of feeder 40 may advance the guidewire by more than 1 cm, e.g., more than 3 cm, such as more than 4 cm.


It is to be noted that the term “generally not exposed” does not necessarily preclude small portions of the guidewire from being exposed, such as portions that are less than 1 cm in length; typically less than 3 mm of guidewire (e.g., less than 1 mm of guidewire) is exposed. It is also to be noted that although tubular member 48 is typically more rigid than guidewire 42, the tubular member may be somewhat flexible, such as to accommodate use of feeder 40 at different angles, e.g., due to position of the feeder, the subject, the physician, etc.


To facilitate coupling of guidewire feeder 40 to medical device 41 and/or the body of the subject, the guidewire feeder typically comprises a coupling member 90, such as a strap. Coupling member 90 may alternatively or additionally comprise a pin, a latch, and/or another coupling member. Feeder 40 (e.g., first housing 44 thereof) may additionally comprise an indicator, such as a visual and/or tactile indicator to facilitate positioning of the feeder with respect to medical device 41.


For some applications, coupling member 90 is configured to be coupled to a specific medical device, thereby facilitating coupling of feeder 40 to the specific medical device. For some applications, coupling member 90 is couplable to a range of medical devices; that is, the coupling member comprises a generic coupling member. For example, when coupling member 90 comprises a strap, the strap may be placeable around a portion of a medical device without having being matched to that particular medical device. Typically, first housing 44 is shaped to facilitate coupling to the specific medical device and/or the range of medical devices, such as by being shaped to define a concavity 92 in which a portion of the medical device is placeable. Device 41 typically defines a conduit therethrough, and an opening via which the guidewire is introducible into the conduit. Feeder 40 is typically configured to be coupled to device 41 such that first channel 54 (e.g., an end thereof) is aligned with the opening of the conduit of device 41, such that guidewire can slide freely between the second channel and the conduit.


Reference is now made to FIGS. 3A-B, and 4A-B, which are schematic illustrations of guidewire feeder 40, in accordance with some applications of the invention. Typically, guidewire-engaging element 60 is reversibly engageable (e.g., movable between an engaged state and a disengaged state thereof) using an engagement switch 80. FIGS. 3A-B show solid and cross-sectional views, respectively, of feeder 40 in the disengaged state, and FIGS. 4A-B show solid and cross-sectional views, respectively, of the feeder in the engaged state. Typically, guidewire-engaging element 60 is not in contact with guidewire 42 in the disengaged state, and is in contact with the guidewire in the engaged state.


Engagement switch 80 is typically pivotally coupled, by a bearing 82, to second housing 46, such as with at least part of switch 80 being disposed within a space 47 defined by the second housing. An operating physician may move switch 80 (e.g., using a thumb), so as to move element 60 between (1) the disengaged state, in which the guidewire is typically freely slidable in both directions through second channel 56, e.g., so as to introduce the guidewire through the second channel, and (2) the engaged state, in which the guidewire is inhibited from moving through the second channel away from the first housing, e.g., so as to use feeder 40 to advance the guidewire distally into the body of the subject. Typically, engagement switch 80 applies a force to guidewire-engaging element 60 so as to move the guidewire-engaging element into the disengaged state. For example, a spring 68 may be configured to move element 60 into the engaged state by applying a force, and switch 80 may be configured to (1) move the guidewire-engaging element into the disengaged state by applying an opposing force to the force applied by the spring, and (2) move the guidewire-engaging element into the engaged state by removing the opposing force, thereby allowing the spring to move the guidewire-engaging element into the engaged state.


For some applications, guidewire-engaging element 60 defines a protrusion 70 that is configured to abut an abutment (e.g., defined by second housing 46), so as to limit rotation of the guidewire-engaging element around bearing 64, e.g., to prevent guidewire-engaging element from rotating too far when engagement switch 80 moves the guidewire-engaging element into the disengaged state.


Reference is made to FIGS. 5A-D, which are schematic illustrations of guidewire feeder 40, in the engaged state thereof, being used to advance guidewire 42, in accordance with some applications of the invention. While element 60 is in the engaged state, when the guidewire moves through channel 56 toward first housing 44, element 60 responsively grips the guidewire (e.g., increases its grip on the guidewire compared to when the guidewire moves through channel 56 away from the first housing).


For some applications, and as shown in the figures, guidewire-engaging element 60 defines or comprises a guidewire-engaging edge 62 and is configured such that, while the guidewire is disposed within second channel 56, and element 60 is in the engaged state, the guidewire-engaging edge is disposed against the guidewire at an angle such that if the guidewire begins to move through channel 56 away from first housing 44, element 60 grips the guidewire (e.g., edge 62 presses into and/or catches against the guidewire). When guidewire 42 moves through channel 56 toward first housing 44 (i.e., in the opposite direction), guidewire-engaging element 60 does not grip the guidewire, and the guidewire slides past the guidewire-engaging element, typically with edge 62 in light contact with the guidewire. Typically, edge 62 comprises and/or is defined by a hard material, such as cubic zirconia, aluminium oxide (e.g., alpha-aluminium oxide), cemented carbide (e.g., widia), and/or a hardened metal. For some applications, edge 62 defines a plurality of teeth. For some applications, edge 62 comprises a soft material, such as silicone rubber, that applies friction to the guidewire.



FIG. 5A shows guidewire feeder 40 in a state in which second housing 46 is at a maximum distance d1 from first housing 44 (e.g., a starting position). Typically, when guidewire 42 is stationary within channel 56, guidewire-engaging edge 62 is disposed with respect to guidewire 42 (e.g., against guidewire 42) at a nonzero angle alpha_A that is further typically not a right angle (FIG. 5A). Angle alpha_A is typically an obtuse angle defined between a longitudinal axis a2 of guidewire-engaging edge 62, and a portion of guidewire 42 and/or axis a1 that is disposed closer to tubular member 48 than is the guidewire-engaging edge. An angle defined between guidewire-engaging edge 62 and a portion of channel 56 that is disposed closer to tubular member 48 than is the guidewire-engaging edge, is also typically obtuse.


Guidewire-engaging element 60 is typically pivotally coupled, by a bearing 64, to second housing 46, such as within space 47. Typically, guidewire-engaging element is maintained in the engaged state thereof by spring 68 (e.g., when engagement switch 80 does not hold element 60 in the disengaged state). For example, spring 68 may bias guidewire-engaging element 60 such that edge 62 is disposed against guidewire 42, e.g., by rotating the guidewire-engaging element around bearing 64. That is, spring 68 typically maintains guidewire-engaging element 60 (e.g., guidewire-engaging edge 62 thereof) (1) disposed against guidewire 42, and/or (2) disposed at a predetermined angle with respect to the guidewire.


When second housing 46 is moved toward first housing 44, guidewire 42 begins to move through channel 56, guidewire-engaging element 60 responsively grips the guidewire (e.g., edge 62 presses into and/or catches against the guidewire), and the guidewire is thereby pushed toward the first housing (FIG. 5B). Typically, and as shown by arrow 102 in FIG. 5B, guidewire-engaging element 60 grips the guidewire by rotating slightly, e.g., around bearing 64, such that an angle alpha_B, defined between axis a2 and the portion of guidewire 42 and/or axis a1 that is disposed closer to tubular member 48 than is the guidewire-engaging edge, is smaller than angle alpha_A. Angle alpha_B is typically closer to a right angle than is angle alpha_A. It is to be noted that a portion 100 of guidewire 42 that is disposed within tubular member 48 is moved, while stationary within the tubular member, into first channel 54.



FIG. 5C shows second housing 46 stationary at a closest position thereof to first housing 44. Typically, in this position, second housing 46 abuts first housing 44. Although FIG. 5C shows guidewire-engaging element 60 gripping (e.g., edge 62 pressing into and/or catching against) guidewire 42, for some applications, in this stationary position (and/or in other stationary positions), the guidewire-engaging element does not grip the guidewire, but instead only grips the guidewire when the guidewire moves in the appropriate direction with respect to the guidewire-engaging element. It is to be noted that a length d2 of guidewire 42 that has advanced out of first housing 44 since the state shown in FIG. 5A, is typically approximately equal to distance d1.



FIG. 5D shows second housing 46 being moved away from first housing 44 again, e.g., toward the starting position shown in FIG. 5A. When second housing 46 is moved away from first housing 44, guidewire-engaging element 60 does not grip guidewire 42, and the second housing slides over the guidewire, typically with edge 62 in light contact with the guidewire. That is, guidewire 42 moves through channel 56 in the opposite direction to that shown in FIG. 5B. Guidewire 42 typically remains stationary with respect to first housing 44. Typically, and as shown by arrow 104 in FIG. 5D, guidewire-engaging element 60 typically releases its grip on the guidewire by rotating slightly, e.g., around bearing 64, as guidewire 42 begins to move through channel 56. It will be understood that oscillation of second housing 46 toward and away from first housing 44, results in a net movement of guidewire through guidewire feeder 40 in a direction from second housing 46 to first housing 44.


For some applications, some of the force applied to second housing 46 to move the second housing toward first housing 44, increases gripping of guidewire 42 by guidewire-engaging element 60, and release of this force (e.g., when moving the second housing away from the first housing) releases at least some of this gripping (e.g., such that the gripping is overcome by friction between the guidewire and device 41 and/or the first housing).


Reference is made to FIG. 6, which is a schematic illustration of guidewire feeder 40 being used to advance guidewire 42 into the femoral vein of a subject 120, in accordance with some applications of the invention. As described hereinabove (e.g., with reference to FIG. 1), for some applications guidewire feeder 40 is configured to be used with another medical device, typically by being coupled to the other medical device (e.g., using coupling member 90). For some applications, and as shown in FIG. 6, guidewire feeder 40 is configured to be coupled to the subject being treated, such as by securing coupling member 90 around the thigh of the subject. For some such applications, first housing 44 is shaped to define, or is coupled to, a cannula that facilitates entry of guidewire 42 into a blood vessel of the subject, such as the femoral vein of the subject (e.g., as described with reference to FIG. 7, mutatis mutandis). It is to be noted that guidewire feeder 140, described with reference to FIG. 7, may be used with the techniques described with reference to FIG. 6, mutatis mutandis.


Reference is made to FIG. 7, which is a schematic illustration of a guidewire feeder 140, for use with guidewire 42 and a cannula 150 that defines at least a first lumen 151 therethrough, in accordance with some applications of the invention. Together, guidewire feeder 140 and cannula 150 define a system 160. System 160 typically further comprises guidewire 42, described hereinabove. For some applications, cannula 150 defines a secondary lumen 153 in the wall of the catheter, lumen 153 typically providing dedicated access for guidewire 42, and lumen 151 typically providing access for other apparatus. Typically, when a dedicated guidewire lumen such as lumen 153 is provided, the guidewire fits snugly within that lumen. It is hypothesized that this snug fit facilitates the pushing of the guidewire without the guidewire bending, and/or makes the use of guidewire feeder 40 more advantageous due to increased friction on the guidewire.


For some applications guidewire feeder 140 comprises the same components of and/or performs the same functions of guidewire feeder 40, described hereinabove, mutatis mutandis. For example, guidewire feeder 140 comprises a first housing 144, a second housing 146, and a tubular member 148 that is coupled to the second housing and slidably coupled to the first housing. First housing 144 defines or is coupled to a pipe 154 that defines a first channel therethrough, which is typically analogous to first channel 54 of guidewire feeder 40, described hereinabove. Second housing 146 defines a second channel therethrough (not shown), and tubular member 148 defines a lumen therethrough, and provides communication between the first channel and the second channel. Typically, tubular member 148 is slidably coupled to first housing 144 by being slidable within pipe 154 (e.g., within the first channel). Tubular member 148 is typically fixedly coupled to second housing, such as by a portion of the tubular member being fixedly coupled within a portion of the second channel. Guidewire feeder 140 further comprises a guidewire-engaging element (not shown) that is coupled to and/or disposed within second housing 146, and is configured to selectively inhibit the guidewire from sliding through the second channel away from the first housing.


Typically, the guidewire-engaging element of guidewire feeder 140 comprises guidewire-engaging element 60, described hereinabove. As described hereinabove for guidewire feeder 40, oscillation of the second housing toward and away from the first housing moves the guidewire disposed therewithin in a single direction through the first housing. First housing 144 is configured to be reversibly coupled (e.g., reversibly attached) to cannula 150, so as to facilitate advancement of guidewire 42 into the body of the subject, e.g., as described for the coupling of guidewire feeder 40 to medical device 41 hereinabove, mutatis mutandis. For some applications, cannula 150 comprises medical device 41. Cannula 150 typically comprises a coupling portion 152, configured to be reversibly coupled to first housing 144, which is typically shaped to define a complementary coupling portion 145. For some applications, coupling portion 152 comprises a valve or similar element to inhibit blood from flowing out via the coupling portion. For some applications, coupling portions 152 and 145 comprise Luer-type fittings. For some applications, guidewire-feeder 140 is configured to be coupled to a generic cannula (e.g., cannula 150 defines a generic cannula). For some applications, guidewire feeder 140 is identical to guidewire feeder 40, except for the shape and/or coupling properties of first housing 144. It is to be noted that in this context, throughout this application, including the specification and the claims, the term “cannula” is used as a general term for a percutaneous access device, and may include, by way of example and not limitation, a hollow needle or a catheter.


Typically, guidewire 42 is typically generally not exposed between second housing 146 and a distal end of cannula 150 (i.e., the end of the cannula that is furthest from feeder 140). For example, cannula 150 may be transluminally advanced to the heart of the subject, and guidewire 42 is enclosed within feeder 140 and cannula 150, from when the guidewire enters second housing 146 until it emerges from the distal end of the cannula in the heart of the subject. That is, the guidewire is inhibited from bending from a point of pushing of the guidewire (i.e., second housing 146, e.g., the guidewire-engaging element thereof), to the distal end of the cannula.


Reference is made to FIGS. 8A-B, which are schematic illustrations of guidewire feeder 40 being used to facilitate movement of a medical device 180 with respect to at least a portion of guidewire 42, in accordance with some applications of the invention. For some applications, medical device 180 comprises medical device 41, described hereinabove. For some applications, medical device 180 comprises a handle 182 and a cannula, such as cannula 150, described with reference to FIG. 7, mutatis mutandis. Guidewire feeder 40 is couplable to device 180 such that first housing 44 (e.g., first channel 54 thereof) is aligned with an entry point on device 180 for guidewire 42. Typically, guidewire feeder 40 is couplable to handle 182 using coupling member 90, handle 182 defining the entry point for guidewire 42 into device 180.



FIG. 8A shows medical device 180 with cannula 150 thereof having been advanced into the subject (e.g., percutaneously advanced, such as transluminally advanced). By way of illustration and not limitation, cannula 150 is shown having been advanced transfemorally, via inferior vena cava 12 of the subject, transseptally into left atrium 14 of the heart, and into left ventricle 16 of the heart. For some applications, and as shown in FIGS. 8A-B, cannula 150 is advanced via an outer sheath 190. FIG. 8A shows guidewire 42 disposed within cannula 150. For example, cannula 150 may have been advanced to the heart over guidewire 42. Alternatively, guidewire 42 may have been advanced through cannula 150 (e.g., using feeder 40) subsequent to the advancement of the cannula. For some applications, it is desirable to subsequently move guidewire 42 with respect to device 180 (e.g., cannula 150 thereof).


Moving guidewire 42 proximally with respect to device 180 is typically not challenging. For example, to withdraw guidewire 42 from the body of the subject, a pulling force is typically applied to the guidewire to pull the guidewire proximally while holding device 180 still. Similarly, to initially advance device 180 over guidewire 42, device 180 is pushed distally while maintaining a pulling force to the guidewire to hold the guidewire still. In contrast, and as described hereinabove, moving guidewire 42 distally with respect to device 180 (e.g., by applying a pushing force to the guidewire) is typically difficult and/or inefficient due to bending of the portion of the guidewire that is between the point of pushing and a point of entry of the guidewire into device 180. Guidewire feeder 40 may be used to initially advance (e.g., push) guidewire 42 through medical device 180, such as in a manner described hereinabove, mutatis mutandis. Furthermore, and as shown in FIGS. 8A-B, feeder 40 may be used to facilitate withdrawal of device 180 from the body of the subject, while keeping guidewire 42 still with respect to the body of the subject, e.g., so as to facilitate the subsequent advancement of another medical device and/or an implant over the same guidewire.


As described hereinabove, FIG. 8A shows cannula 150 of medical device 180 having been advanced into the subject, and guidewire 42 disposed within the cannula. An operating physician withdraws cannula 150 proximally (e.g., by pulling handle 182 proximally) while simultaneously pushing second housing 46 of feeder 40 toward first housing 44, thereby applying a pushing force on guidewire 42, such that the distal end of the guidewire remains stationary with respect to the body of the subject (FIG. 8B). Typically, the distance and/or speed that second housing 46 is pushed toward first housing 44 is relative (although not necessarily identical) to the distance and/or speed that the cannula is withdrawn. Second housing 46 is subsequently moved away from first housing 44, and the process is repeated (e.g., the second housing is oscillated) until a desired degree of withdrawal of cannula 150 (e.g., complete withdrawal from the body of the subject) is achieved. Typically, the operating physician holds medical device 180 (e.g., handle 182 thereof) with one hand, and operates feeder 40 with the other hand (e.g., by holding second housing 46 with the thumb and forefinger).


Guidewire feeder 40 is particularly advantageous in transluminal (e.g., transfemoral) cardiac procedures, for which withdrawal of cannula 150 typically comprises withdrawal over greater than 80 cm (e.g., greater than 1 m), e.g., due to the increased ‘stroke’ length described hereinabove. For some applications, imaging (e.g., fluoroscopy and/or echo) are used to observe the position of cannula 150 and/or guidewire 42 within the body of the subject, such as in real-time so as to facilitate maintenance of the position of the distal end of the guidewire, while retracting cannula 150 from the subject.


Reference is again made to FIGS. 7 and 8A-B. It is to be noted that guidewire feeder 140, described with reference to FIG. 7, may also be used with the techniques described with reference to FIGS. 8A-B.


Reference is again made to FIGS. 1-8. Typically, second housing 46 is shaped to define a handle that is configured (e.g., shaped) to facilitate gripping and operation thereof by the operating physician using only a thumb 122 and forefinger 124 (e.g., as shown in FIG. 6). For some applications, such gripping of second housing 46 by the operating physician is the only point at which the operating physician directly contacts guidewire feeder 40.


Reference is again made to FIGS. 1-8. Although first housing 44 and second housing 46 are shown throughout in the same rotational position around axis a1 with respect to each other, the housings are typically rotatable around axis a1 with respect to each other. For example, while first housing is coupled to medical device 41, second housing 46 is typically freely rotatable around axis a1. For some applications, such free rotation is facilitated by tubular member 48 being freely rotatable within first channel 56. Such free rotation may facilitate effective and/or comfortable use of guidewire feeder 40 by the operating physician. For some applications, this free rotation is partly inhibited while second housing 46 is being pushed toward first housing 44, and guidewire-engaging element 60 is gripping guidewire 42 (e.g., due to the gripping of the guidewire by the guidewire-engaging element).


Reference is again made to FIGS. 1-8. It is to be noted that, although the example of a guidewire (i.e., guidewire 42) is used throughout this application, feeder 40 may also be used to facilitate feeding of other longitudinal (and typically flexible) elements, such as tubular longitudinal elements, e.g., catheters, mutatis mutandis.


Reference is again made to FIGS. 1-8. For some applications, guidewire feeder 40 is integrated with a medical device, such as device 41 or device 180. For example, handle 182 of device 180 may define the first housing of the guidewire feeder, tubular member 48 being slidably coupled to the handle.


It will be understood that, although the terms “first,” “second,” etc. may be used in the present application (including the specification and the claims) to describe various elements and/or directions, these terms should not be limiting. These terms are only used to distinguish one element and/or direction from another. Thus, a “first” element described herein could also be termed a “second” element without departing from the teachings of the present disclosure.


It will be appreciated by persons skilled in the art that the present invention is not limited to what has been particularly shown and described hereinabove. Rather, the scope of the present invention includes both combinations and subcombinations of the various features described hereinabove, as well as variations and modifications thereof that are not in the prior art, which would occur to persons skilled in the art upon reading the foregoing description.

Claims
  • 1. Apparatus for use with a guidewire, the apparatus comprising a guidewire feeder, which comprises: a first housing, shaped to define a first channel through which the guidewire is slidable;a second housing, shaped to define a second channel through which the guidewire is slidable in at least a first direction toward the first housing;a guidewire-engaging element, which is disposed within the second housing, and which is configured to inhibit the guidewire from sliding through the second channel in a second direction away from the first housing, and to allow the guidewire to slide through the second channel in the first direction toward the first housing; anda tubular member, which is shaped to define a lumen through which the guidewire is slidable, is coupled to the second housings and is slidably coupled to the first housing, such that the second housing is slidable in directions toward and away from the first housing,wherein the guidewire feeder is arranged such that oscillation of the second housing toward and away from the first housing advances the guidewire in the first direction through the first channel of the first housing, by:movement of the second housing toward the first housing sliding a portion of the guidewire that is disposed within the tubular member in the first direction, with the tubular member, into the first housing, andmovement of the second housing away from the first housing sliding the tubular member in the second direction out of the first housing and over the portion of the guidewire, while the guidewire remains stationary with respect to the first housing.
  • 2. The apparatus according to claim 1, wherein the tubular member is slidable within the first channel.
  • 3. The apparatus according to claim 1, wherein: the guidewire-engaging element has an engaged state and a disengaged state, and is configured to inhibit the guidewire from sliding through the second channel in the second direction, only when in the engaged state, andthe apparatus further comprises an engagement switch, configured to reversibly move the guidewire-engaging element between the engaged state and the disengaged state.
  • 4. The apparatus according to claim 1, wherein the apparatus is configured to facilitate percutaneous advancement of the guidewire by a physician, while the physician (a) directly holds the second housing of the apparatus with only one finger and one thumb, and (b) does not directly hold the first housing.
  • 5. The apparatus according to claim 1, wherein the lumen of the tubular member provides communication between the first channel and the second channel.
  • 6. The apparatus according to claim 1, further comprising the guidewire, wherein the tubular member is more rigid than the guidewire, and is configured to inhibit bending of the portion of the guidewire that is disposed within the lumen of the tubular member.
  • 7. The apparatus according to claim 1, wherein the first channel, the second channel, and the lumen are collinear.
  • 8. The apparatus according to claim 7, wherein the first channel, the second channel, and the lumen define an axis, and wherein the second housing is rotatable around the axis.
  • 9. The apparatus according to claim 2, wherein the apparatus is configured such that, when the second housing slides toward the first housing, the tubular member slides into the first channel.
  • 10. The apparatus according to claim 1, wherein the apparatus is further for use with a device for facilitating percutaneous procedures, and wherein the first housing is configured to be coupled to the device.
  • 11. The apparatus according to claim 10, wherein the first housing comprises coupling means, configured to facilitate coupling the first housing to the device.
  • 12. The apparatus according to claim 1, wherein the guidewire-engaging element is configured to inhibit the guidewire from sliding through the second channel in the second direction by gripping the guidewire.
  • 13. The apparatus according to claim 12, wherein the guidewire-engaging element is pivotally coupled to the second housing.
  • 14. The apparatus according to claim 12, wherein the guidewire-engaging element defines a guidewire-engaging edge, and is configured such that, while the guidewire is disposed within the second channel, the guidewire-engaging edge is disposed against the guidewire at an angle, such that movement of the guidewire in the second direction through the second channel causes the guidewire-engaging edge to press into the guidewire.
  • 15. The apparatus according to claim 14, wherein the angle is with respect to a portion of the guidewire that is disposed closer to the tubular member than is the guidewire-engaging edge, andwherein the guidewire-engaging element is configured such that, while the guidewire is disposed within the second channel:when the second housing is moved toward the first housing, the guidewire-engaging edge pushes the guidewire toward the first housing by pressing into the guidewire by rotating such that the angle decreases and becomes closer to a right angle.
  • 16. The apparatus according to claim 14, wherein the guidewire-engaging edge is configured such that, while the guidewire is disposed within the second channel, the guidewire-engaging edge is disposed against the guidewire at an obtuse angle with respect to a portion of the guidewire that is disposed closer to the tubular member than is the guidewire-engaging edge.
  • 17. A method for use with a guidewire, the method comprising: providing a guidewire feeder including: a first housing, shaped to define a first channel through which the guidewire is slidable;a second housing, shaped to define a second channel through which the guidewire is slidable in at least a first direction toward the first housing;a guidewire-engaging element, which is disposed within the second housing, and which is configured to inhibit the guidewire from sliding through the second channel in a second direction away from the first housing, and to allow the guidewire to slide through the second channel in the first direction toward the first housing; anda tubular member, which is shaped to define a lumen through which the guidewire is slidable, is coupled to the second housing, and is slidably coupled to the first housing, such that the second housing is slidable in directions toward and away from the first housing; andadvancing the guidewire in the first direction through the first channel of the first housing by oscillating the second housing toward and away from the first housing by: sliding a portion of the guidewire that is disposed within the tubular member in the first direction through the first housing by sliding the tubular member into the first housing, by moving the second housing toward the first housing; andsliding the tubular member in the second direction out of the first housing and over the portion of the guidewire by moving the second housing away from the first housing, while the guidewire remains stationary with respect to the first housing.
  • 18. The method according to claim 17, wherein providing the guidewire feeder comprises providing the guidewire feeder in which the guidewire-engaging element is configured to inhibit the guidewire from sliding through the second channel in the second direction by gripping the guidewire.
  • 19. The method according to claim 17, wherein the tubular member is slidable within the first channel.
  • 20. The method according to claim 19, wherein the apparatus is configured such that, when the second housing slides toward the first housing, the tubular member slides into the first channel.
CROSS-REFERENCES TO RELATED APPLICATIONS

The present application claims priority from U.S. provisional patent application 61/782,121 to Hammer et al., filed Mar. 14, 2013, and entitled “Guidewire Feeder”, which is incorporated herein by reference.

US Referenced Citations (669)
Number Name Date Kind
3604488 Wishart et al. Sep 1971 A
3656185 Carpentier Apr 1972 A
3840018 Heifetz Oct 1974 A
3898701 La Russa Aug 1975 A
4042979 Angell Aug 1977 A
4118805 Reimels Oct 1978 A
4214349 Munch Jul 1980 A
4261342 Aranguren Duo Apr 1981 A
4290151 Massana Sep 1981 A
4434828 Trincia Mar 1984 A
4473928 Johnson Oct 1984 A
4602911 Ahmadi et al. Jul 1986 A
4625727 Leiboff Dec 1986 A
4712549 Peters et al. Dec 1987 A
4778468 Hunt et al. Oct 1988 A
4917698 Carpentier et al. Apr 1990 A
4961738 Mackin Oct 1990 A
5061277 Carpentier et al. Oct 1991 A
5064431 Gilbertson et al. Nov 1991 A
5104407 Lam et al. Apr 1992 A
5108420 Marks Apr 1992 A
5201880 Wright et al. Apr 1993 A
5258008 Wilk Nov 1993 A
5300034 Behnke et al. Apr 1994 A
5306296 Wright et al. Apr 1994 A
5325845 Adair Jul 1994 A
5346498 Greelis Sep 1994 A
5450860 O'Connor Sep 1995 A
5474518 Farrer Velazquez Dec 1995 A
5477856 Lundquist Dec 1995 A
5593424 Northrup, III Jan 1997 A
5601572 Middleman et al. Feb 1997 A
5669919 Sanders et al. Sep 1997 A
5674279 Wright et al. Oct 1997 A
5683402 Cosgrove et al. Nov 1997 A
5702397 Goble et al. Dec 1997 A
5702398 Tarabishy Dec 1997 A
5709695 William et al. Jan 1998 A
5716370 Williamson, IV et al. Feb 1998 A
5716397 Myers Feb 1998 A
5730150 Peppel Mar 1998 A
5749371 Zadini May 1998 A
5810882 Bolduc et al. Sep 1998 A
5824066 Gross Oct 1998 A
5843120 Israel et al. Dec 1998 A
5855614 Stevens et al. Jan 1999 A
5876373 Giba et al. Mar 1999 A
5935098 Blaisdell et al. Aug 1999 A
5957953 DiPoto et al. Sep 1999 A
5961440 Schweich, Jr. et al. Oct 1999 A
5961539 Northrup, III et al. Oct 1999 A
5984959 Robertson et al. Nov 1999 A
6042554 Rosenman et al. Mar 2000 A
6045497 Schweich, Jr. et al. Apr 2000 A
6050936 Schweich, Jr. et al. Apr 2000 A
6059715 Schweich, Jr. et al. May 2000 A
6074401 Gardiner et al. Jun 2000 A
6074417 Peredo Jun 2000 A
6102945 Campbell Aug 2000 A
6106550 Magovern et al. Aug 2000 A
6110200 Hinnenkamp Aug 2000 A
6143024 Campbell et al. Nov 2000 A
6159240 Sparer et al. Dec 2000 A
6165119 Schweich, Jr. et al. Dec 2000 A
6174332 Loch et al. Jan 2001 B1
6183411 Mortier et al. Feb 2001 B1
6187040 Wright Feb 2001 B1
6217610 Carpentier et al. Apr 2001 B1
6231602 Carpentier et al. May 2001 B1
6251092 Qin et al. Jun 2001 B1
6315784 Djurovic Nov 2001 B1
6319281 Patel Nov 2001 B1
6332893 Mortier et al. Dec 2001 B1
6368348 Gabbay Apr 2002 B1
6402780 Williamson, IV et al. Jun 2002 B2
6406420 McCarthy et al. Jun 2002 B1
6406493 Tu et al. Jun 2002 B1
6419696 Ortiz et al. Jul 2002 B1
6451054 Stevens Sep 2002 B1
6461366 Seguin Oct 2002 B1
6470892 Forsell Oct 2002 B1
6503274 Howanec, Jr. et al. Jan 2003 B1
6524338 Gundry Feb 2003 B1
6537314 Langberg et al. Mar 2003 B2
6547801 Dargent et al. Apr 2003 B1
6554845 Fleenor et al. Apr 2003 B1
6564805 Garrison et al. May 2003 B2
6565603 Cox May 2003 B2
6569198 Wilson et al. May 2003 B1
6579297 Bicek et al. Jun 2003 B2
6589160 Schweich, Jr. et al. Jul 2003 B2
6602288 Cosgrove et al. Aug 2003 B1
6602289 Colvin et al. Aug 2003 B1
6613078 Barone Sep 2003 B1
6613079 Wolinsky et al. Sep 2003 B1
6619291 Hlavka et al. Sep 2003 B2
6626899 Houser et al. Sep 2003 B2
6626930 Allen et al. Sep 2003 B1
6629534 St. Goar et al. Oct 2003 B1
6629921 Schweich, Jr. et al. Oct 2003 B1
6651671 Donlon et al. Nov 2003 B1
6652556 VanTassel et al. Nov 2003 B1
6682558 Tu et al. Jan 2004 B2
6689125 Keith et al. Feb 2004 B1
6689164 Seguin Feb 2004 B1
6695866 Kuehn et al. Feb 2004 B1
6702826 Liddicoat et al. Mar 2004 B2
6702846 Mikus et al. Mar 2004 B2
6706065 Langberg et al. Mar 2004 B2
6709385 Forsell Mar 2004 B2
6709456 Langberg et al. Mar 2004 B2
6711444 Koblish Mar 2004 B2
6718985 Hlavka et al. Apr 2004 B2
6719786 Ryan et al. Apr 2004 B2
6723038 Schroeder et al. Apr 2004 B1
6726716 Marquez Apr 2004 B2
6726717 Alfieri et al. Apr 2004 B2
6749630 McCarthy et al. Jun 2004 B2
6752813 Goldfarb et al. Jun 2004 B2
6764510 Vidlund et al. Jul 2004 B2
6770083 Seguin Aug 2004 B2
6786924 Ryan et al. Sep 2004 B2
6786925 Schoon et al. Sep 2004 B1
6790231 Liddicoat et al. Sep 2004 B2
6797001 Mathis et al. Sep 2004 B2
6797002 Spence et al. Sep 2004 B2
6802319 Stevens et al. Oct 2004 B2
6805710 Bolling et al. Oct 2004 B2
6855126 Flinchbaugh Feb 2005 B2
6858039 McCarthy Feb 2005 B2
6884250 Monassevitch et al. Apr 2005 B2
6893459 Macoviak May 2005 B1
6908482 McCarthy et al. Jun 2005 B2
6918917 Nguyen et al. Jul 2005 B1
6926730 Nguyen et al. Aug 2005 B1
6960217 Bolduc Nov 2005 B2
6964684 Ortiz et al. Nov 2005 B2
6976995 Mathis et al. Dec 2005 B2
6986775 Morales et al. Jan 2006 B2
6989028 Lashinski et al. Jan 2006 B2
6997951 Solem et al. Feb 2006 B2
7004176 Lau Feb 2006 B2
7011669 Kimblad Mar 2006 B2
7011682 Lashinski et al. Mar 2006 B2
7037334 Hlavka et al. May 2006 B1
7077862 Vidlund et al. Jul 2006 B2
7087064 Hyde Aug 2006 B1
7101395 Tremulis et al. Sep 2006 B2
7112207 Allen et al. Sep 2006 B2
7118595 Ryan et al. Oct 2006 B2
7125421 Tremulis et al. Oct 2006 B2
7150737 Purdy et al. Dec 2006 B2
7159593 McCarthy et al. Jan 2007 B2
7166127 Spence et al. Jan 2007 B2
7169187 Datta et al. Jan 2007 B2
7172625 Shu et al. Feb 2007 B2
7175660 Cartledge et al. Feb 2007 B2
7186262 Saadat Mar 2007 B2
7186264 Liddicoat et al. Mar 2007 B2
7189199 McCarthy et al. Mar 2007 B2
7192443 Solem et al. Mar 2007 B2
7226467 Lucatero et al. Jun 2007 B2
7226477 Cox Jun 2007 B2
7226647 Kasperchik et al. Jun 2007 B2
7238191 Bachmann Jul 2007 B2
7288097 Seguin Oct 2007 B2
7294148 McCarthy Nov 2007 B2
7297150 Cartledge et al. Nov 2007 B2
7311728 Solem et al. Dec 2007 B2
7311729 Mathis et al. Dec 2007 B2
7314485 Mathis Jan 2008 B2
7316710 Cheng et al. Jan 2008 B1
7329280 Bolling et al. Feb 2008 B2
7335213 Hyde et al. Feb 2008 B1
7361190 Shaoulian et al. Apr 2008 B2
7364588 Mathis et al. Apr 2008 B2
7377941 Rhee et al. May 2008 B2
7390329 Westra et al. Jun 2008 B2
7404824 Webler et al. Jul 2008 B1
7431692 Zollinger et al. Oct 2008 B2
7442207 Rafiee Oct 2008 B2
7452376 Lim et al. Nov 2008 B2
7455690 Cartledge et al. Nov 2008 B2
7485142 Milo Feb 2009 B2
7485143 Webler et al. Feb 2009 B2
7500989 Solem et al. Mar 2009 B2
7507252 Lashinski et al. Mar 2009 B2
7510577 Moaddeb et al. Mar 2009 B2
7527647 Spence May 2009 B2
7530995 Quijano et al. May 2009 B2
7549983 Roue et al. Jun 2009 B2
7559936 Levine Jul 2009 B2
7563267 Goldfarb et al. Jul 2009 B2
7563273 Goldfarb et al. Jul 2009 B2
7569062 Kuehn et al. Aug 2009 B1
7588582 Starksen et al. Sep 2009 B2
7591826 Alferness et al. Sep 2009 B2
7604646 Goldfarb et al. Oct 2009 B2
7608091 Goldfarb et al. Oct 2009 B2
7608103 McCarthy Oct 2009 B2
7618449 Tremulis et al. Nov 2009 B2
7632303 Stalker et al. Dec 2009 B1
7635329 Goldfarb et al. Dec 2009 B2
7635386 Gammie Dec 2009 B1
7655015 Goldfarb et al. Feb 2010 B2
7666204 Thornton et al. Feb 2010 B2
7682319 Martin et al. Mar 2010 B2
7682369 Seguin Mar 2010 B2
7699892 Rafiee et al. Apr 2010 B2
7704269 St. Goar et al. Apr 2010 B2
7704277 Zakay et al. Apr 2010 B2
7736388 Goldfarb et al. Jun 2010 B2
7753924 Starksen et al. Jul 2010 B2
7871368 Zollinger et al. Jan 2011 B2
7871433 Lattouf Jan 2011 B2
7927370 Webler et al. Apr 2011 B2
7927371 Navia et al. Apr 2011 B2
7942927 Kaye et al. May 2011 B2
7988725 Gross et al. Aug 2011 B2
7992567 Hirotsuka et al. Aug 2011 B2
7993368 Gambale et al. Aug 2011 B2
7993397 Lashinski et al. Aug 2011 B2
8012201 Lashinski et al. Sep 2011 B2
8034103 Burriesci et al. Oct 2011 B2
8052592 Goldfarb et al. Nov 2011 B2
8070804 Hyde et al. Dec 2011 B2
8070805 Vidlund et al. Dec 2011 B2
8075616 Solem et al. Dec 2011 B2
8100964 Spence Jan 2012 B2
8123800 McCarthy et al. Feb 2012 B2
8123801 Milo Feb 2012 B2
8142493 Spence et al. Mar 2012 B2
8142495 Hasenkam et al. Mar 2012 B2
8142496 Berreklouw Mar 2012 B2
8147542 Maisano et al. Apr 2012 B2
8152844 Rao et al. Apr 2012 B2
8163013 Machold et al. Apr 2012 B2
8187299 Goldfarb et al. May 2012 B2
8187324 Webler et al. May 2012 B2
8202315 Hlavka et al. Jun 2012 B2
8206439 Gomez Duran Jun 2012 B2
8226711 Mortier et al. Jul 2012 B2
8231671 Kim Jul 2012 B2
8241351 Cabiri Aug 2012 B2
8252050 Maisano et al. Aug 2012 B2
8277502 Miller et al. Oct 2012 B2
8287584 Salahieh et al. Oct 2012 B2
8287591 Keidar et al. Oct 2012 B2
8303608 Goldfarb et al. Nov 2012 B2
8323334 Deem et al. Dec 2012 B2
8328868 Paul et al. Dec 2012 B2
8333777 Schaller et al. Dec 2012 B2
8343173 Starksen et al. Jan 2013 B2
8343174 Goldfarb et al. Jan 2013 B2
8349002 Milo Jan 2013 B2
8353956 Miller et al. Jan 2013 B2
8357195 Kuehn Jan 2013 B2
8382829 Call et al. Feb 2013 B1
8388680 Starksen et al. Mar 2013 B2
8393517 Milo Mar 2013 B2
8430926 Kirson Apr 2013 B2
8460370 Zakay et al. Jun 2013 B2
8460371 Hlavka et al. Jun 2013 B2
8475491 Milo Jul 2013 B2
8500800 Maisano et al. Aug 2013 B2
8518107 Tsukashima et al. Aug 2013 B2
8523881 Cabiri et al. Sep 2013 B2
8523940 Richardson et al. Sep 2013 B2
8545553 Zipory et al. Oct 2013 B2
8551161 Dolan Oct 2013 B2
8591576 Hasenkam et al. Nov 2013 B2
8628571 Hacohen et al. Jan 2014 B1
8641727 Starksen et al. Feb 2014 B2
8652202 Alon et al. Feb 2014 B2
8715342 Zipory et al. May 2014 B2
8728097 Sugimoto et al. May 2014 B1
8734467 Miller et al. May 2014 B2
8740920 Goldfarb et al. Jun 2014 B2
8747463 Fogarty et al. Jun 2014 B2
8778021 Cartledge Jul 2014 B2
8790367 Nguyen et al. Jul 2014 B2
8795298 Hernlund et al. Aug 2014 B2
8845717 Khairkhahan et al. Sep 2014 B2
8845723 Spence et al. Sep 2014 B2
8852272 Gross et al. Oct 2014 B2
8858623 Miller et al. Oct 2014 B2
8864822 Spence et al. Oct 2014 B2
8888843 Khairkhahan et al. Nov 2014 B2
8911461 Traynor et al. Dec 2014 B2
8911494 Hammer et al. Dec 2014 B2
8932348 Solem et al. Jan 2015 B2
8940042 Miller et al. Jan 2015 B2
8945211 Sugimoto et al. Feb 2015 B2
8951285 Sugimoto et al. Feb 2015 B2
8951286 Sugimoto et al. Feb 2015 B2
9011520 Miller et al. Apr 2015 B2
9017399 Gross et al. Apr 2015 B2
9119719 Zipory et al. Sep 2015 B2
9125632 Loulmet et al. Sep 2015 B2
9173646 Fabro Nov 2015 B2
9180005 Lashinski et al. Nov 2015 B1
9226825 Starksen et al. Jan 2016 B2
9427316 Schweich, Jr. et al. Aug 2016 B2
20010021874 Carpentier et al. Sep 2001 A1
20010044656 Williamson, IV et al. Nov 2001 A1
20020029080 Mortier et al. Mar 2002 A1
20020042621 Liddicoat et al. Apr 2002 A1
20020082525 Oslund Jun 2002 A1
20020087048 Brock et al. Jul 2002 A1
20020103532 Langberg et al. Aug 2002 A1
20020151961 Lashinski et al. Oct 2002 A1
20020151970 Garrison et al. Oct 2002 A1
20020169358 Mortier et al. Nov 2002 A1
20020173841 Ortiz et al. Nov 2002 A1
20020177904 Huxel et al. Nov 2002 A1
20020188301 Dallara et al. Dec 2002 A1
20030018358 Saadat Jan 2003 A1
20030050693 Quijano et al. Mar 2003 A1
20030078465 Pai et al. Apr 2003 A1
20030078653 Vesely et al. Apr 2003 A1
20030083742 Spence et al. May 2003 A1
20030100943 Bolduc May 2003 A1
20030105519 Fasol et al. Jun 2003 A1
20030130731 Vidlund et al. Jul 2003 A1
20030167062 Gambale et al. Sep 2003 A1
20030171760 Gambale Sep 2003 A1
20030191528 Quijano et al. Oct 2003 A1
20030199974 Lee et al. Oct 2003 A1
20030204195 Keane et al. Oct 2003 A1
20030229350 Kay Dec 2003 A1
20030229395 Cox Dec 2003 A1
20030233142 Morales et al. Dec 2003 A1
20040019377 Taylor et al. Jan 2004 A1
20040024451 Johnson et al. Feb 2004 A1
20040039442 St. Goar et al. Feb 2004 A1
20040049207 Goldfarb et al. Mar 2004 A1
20040059413 Argento Mar 2004 A1
20040092962 Thornton et al. May 2004 A1
20040122448 Levine Jun 2004 A1
20040122514 Fogarty et al. Jun 2004 A1
20040127982 Machold et al. Jul 2004 A1
20040127983 Mortier et al. Jul 2004 A1
20040133220 Lashinski et al. Jul 2004 A1
20040133274 Webler et al. Jul 2004 A1
20040138744 Lashinski et al. Jul 2004 A1
20040138745 Macoviak et al. Jul 2004 A1
20040148019 Vidlund et al. Jul 2004 A1
20040148020 Vidlund et al. Jul 2004 A1
20040148021 Cartledge et al. Jul 2004 A1
20040153146 Lashinski et al. Aug 2004 A1
20040172046 Hlavka et al. Sep 2004 A1
20040176788 Opolski Sep 2004 A1
20040181287 Gellman Sep 2004 A1
20040186566 Hindrichs et al. Sep 2004 A1
20040193191 Starksen et al. Sep 2004 A1
20040236419 Milo Nov 2004 A1
20040243227 Starksen et al. Dec 2004 A1
20040249453 Cartledge et al. Dec 2004 A1
20040260393 Rahdert et al. Dec 2004 A1
20040260394 Douk et al. Dec 2004 A1
20040267358 Reitan Dec 2004 A1
20050004668 Aklog et al. Jan 2005 A1
20050010787 Tarbouriech Jan 2005 A1
20050016560 Voughlohn Jan 2005 A1
20050055038 Kelleher et al. Mar 2005 A1
20050055087 Starksen Mar 2005 A1
20050060030 Lashinski et al. Mar 2005 A1
20050065601 Lee et al. Mar 2005 A1
20050070999 Spence Mar 2005 A1
20050075727 Wheatley Apr 2005 A1
20050085903 Lau Apr 2005 A1
20050090827 Gedebou Apr 2005 A1
20050096740 Langberg et al. May 2005 A1
20050107871 Realyvasquez et al. May 2005 A1
20050119734 Spence et al. Jun 2005 A1
20050125002 Baran et al. Jun 2005 A1
20050125011 Spence et al. Jun 2005 A1
20050131533 Alfieri et al. Jun 2005 A1
20050137695 Salahieh et al. Jun 2005 A1
20050159728 Armour et al. Jul 2005 A1
20050171601 Cosgrove et al. Aug 2005 A1
20050177180 Kaganov et al. Aug 2005 A1
20050177228 Solem et al. Aug 2005 A1
20050187613 Bolduc et al. Aug 2005 A1
20050192596 Jugenheimer et al. Sep 2005 A1
20050197696 Gomez Duran Sep 2005 A1
20050203549 Realyvasquez Sep 2005 A1
20050203606 VanCamp Sep 2005 A1
20050216039 Lederman Sep 2005 A1
20050216079 MaCoviak Sep 2005 A1
20050222665 Aranyi Oct 2005 A1
20050222678 Lashinski et al. Oct 2005 A1
20050256532 Nayak et al. Nov 2005 A1
20050273138 To et al. Dec 2005 A1
20050288776 Shaoulian et al. Dec 2005 A1
20050288778 Shaoulian et al. Dec 2005 A1
20050288781 Moaddeb et al. Dec 2005 A1
20060004442 Spenser et al. Jan 2006 A1
20060004443 Liddicoat et al. Jan 2006 A1
20060020326 Bolduc et al. Jan 2006 A9
20060020327 Lashinski et al. Jan 2006 A1
20060020336 Liddicoat Jan 2006 A1
20060025787 Morales et al. Feb 2006 A1
20060025855 Lashinski et al. Feb 2006 A1
20060025858 Alameddine Feb 2006 A1
20060030885 Hyde Feb 2006 A1
20060041319 Taylor et al. Feb 2006 A1
20060052868 Mortier et al. Mar 2006 A1
20060058871 Zakay et al. Mar 2006 A1
20060069429 Spence et al. Mar 2006 A1
20060074486 Liddicoat et al. Apr 2006 A1
20060085012 Dolan Apr 2006 A1
20060095009 Lampropoulos et al. May 2006 A1
20060106423 Weisel et al. May 2006 A1
20060116757 Lashinski et al. Jun 2006 A1
20060122633 To et al. Jun 2006 A1
20060129166 Lavelle Jun 2006 A1
20060149280 Harvie et al. Jul 2006 A1
20060149368 Spence Jul 2006 A1
20060161265 Levine et al. Jul 2006 A1
20060184240 Jimenez et al. Aug 2006 A1
20060184242 Lichtenstein Aug 2006 A1
20060195134 Crittenden Aug 2006 A1
20060241656 Starksen et al. Oct 2006 A1
20060241748 Lee et al. Oct 2006 A1
20060247763 Slater Nov 2006 A1
20060259135 Navia et al. Nov 2006 A1
20060271175 Woolfson et al. Nov 2006 A1
20060282161 Huynh et al. Dec 2006 A1
20060287661 Bolduc et al. Dec 2006 A1
20060287716 Banbury et al. Dec 2006 A1
20070016287 Cartledge et al. Jan 2007 A1
20070016288 Gurskis et al. Jan 2007 A1
20070021781 Jervis et al. Jan 2007 A1
20070027533 Douk Feb 2007 A1
20070027536 Mihaljevic et al. Feb 2007 A1
20070038221 Fine et al. Feb 2007 A1
20070112359 Kimura et al. Feb 2007 A1
20070049942 Hindrichs et al. Mar 2007 A1
20070049970 Belef et al. Mar 2007 A1
20070051377 Douk et al. Mar 2007 A1
20070055206 To et al. Mar 2007 A1
20070080188 Spence et al. Apr 2007 A1
20070083168 Whiting et al. Apr 2007 A1
20070112422 Dehdashtian May 2007 A1
20070112425 Schaller et al. May 2007 A1
20070118151 Davidson May 2007 A1
20070118154 Crabtree May 2007 A1
20070118213 Loulmet May 2007 A1
20070118215 Moaddeb May 2007 A1
20070142907 Moaddeb et al. Jun 2007 A1
20070162111 Fukamachi et al. Jul 2007 A1
20070198082 Kapadia et al. Aug 2007 A1
20070213582 Zollinger et al. Sep 2007 A1
20070219558 Deutsch Sep 2007 A1
20070233239 Navia et al. Oct 2007 A1
20070239208 Crawford Oct 2007 A1
20070244555 Rafiee et al. Oct 2007 A1
20070244556 Rafiee et al. Oct 2007 A1
20070244557 Rafiee et al. Oct 2007 A1
20070250160 Rafiee Oct 2007 A1
20070255397 Ryan et al. Nov 2007 A1
20070255400 Parravicini et al. Nov 2007 A1
20070270755 Von Oepen Nov 2007 A1
20070270943 Solem et al. Nov 2007 A1
20070276437 Call et al. Nov 2007 A1
20070282375 Hindrichs et al. Dec 2007 A1
20070282429 Hauser et al. Dec 2007 A1
20070295172 Swartz Dec 2007 A1
20080004697 Lichtenstein et al. Jan 2008 A1
20080027483 Cartledge et al. Jan 2008 A1
20080035160 Woodson et al. Feb 2008 A1
20080039935 Buch et al. Feb 2008 A1
20080051703 Thornton et al. Feb 2008 A1
20080058595 Snoke et al. Mar 2008 A1
20080065011 Marchand Mar 2008 A1
20080065204 Macoviak et al. Mar 2008 A1
20080086138 Stone et al. Apr 2008 A1
20080086203 Roberts Apr 2008 A1
20080091257 Andreas et al. Apr 2008 A1
20080097523 Bolduc et al. Apr 2008 A1
20080125861 Webler et al. May 2008 A1
20080140116 Bonutti Jun 2008 A1
20080167714 St. Goar et al. Jul 2008 A1
20080177382 Hyde et al. Jul 2008 A1
20080195126 Solem Aug 2008 A1
20080195200 Vidlund et al. Aug 2008 A1
20080208265 Frazier et al. Aug 2008 A1
20080221672 Lamphere et al. Sep 2008 A1
20080228265 Spence Sep 2008 A1
20080243245 Thambar et al. Oct 2008 A1
20080262609 Gross et al. Oct 2008 A1
20080275469 Fanton et al. Nov 2008 A1
20080275551 Alfieri Nov 2008 A1
20080281411 Berreklouw Nov 2008 A1
20080288044 Osborne Nov 2008 A1
20080300629 Surti Dec 2008 A1
20090043153 Zollinger et al. Feb 2009 A1
20090043381 Macoviak et al. Feb 2009 A1
20090054969 Salahieh et al. Feb 2009 A1
20090076586 Hauser et al. Mar 2009 A1
20090076600 Quinn Mar 2009 A1
20090088837 Gillinov et al. Apr 2009 A1
20090099650 Bolduc et al. Apr 2009 A1
20090105816 Olsen et al. Apr 2009 A1
20090125102 Cartledge et al. May 2009 A1
20090149872 Gross et al. Jun 2009 A1
20090171439 Nissl Jul 2009 A1
20090177266 Powell et al. Jul 2009 A1
20090177274 Scorsin et al. Jul 2009 A1
20090177277 Milo Jul 2009 A1
20090222083 Nguyen Sep 2009 A1
20090248148 Shaolian et al. Oct 2009 A1
20090259307 Gross et al. Oct 2009 A1
20090264994 Saadat Oct 2009 A1
20090287304 Dahlgren et al. Nov 2009 A1
20090299409 Coe et al. Dec 2009 A1
20090326648 Machold et al. Dec 2009 A1
20100001038 Levin et al. Jan 2010 A1
20100010538 Juravic et al. Jan 2010 A1
20100023117 Yoganathan et al. Jan 2010 A1
20100023118 Medlock et al. Jan 2010 A1
20100030014 Ferrazzi Feb 2010 A1
20100030328 Seguin et al. Feb 2010 A1
20100042147 Janovsky et al. Feb 2010 A1
20100049313 Alon et al. Feb 2010 A1
20100063542 van der Burg et al. Mar 2010 A1
20100063586 Hasenkam et al. Mar 2010 A1
20100076499 McNamara et al. Mar 2010 A1
20100094248 Nguyen et al. Apr 2010 A1
20100121349 Meier et al. May 2010 A1
20100130992 Machold et al. May 2010 A1
20100152845 Bloom et al. Jun 2010 A1
20100161041 Maisano et al. Jun 2010 A1
20100161042 Maisano et al. Jun 2010 A1
20100161043 Maisano et al. Jun 2010 A1
20100161047 Cabiri Jun 2010 A1
20100168845 Wright Jul 2010 A1
20100174358 Rabkin et al. Jul 2010 A1
20100179574 Longoria et al. Jul 2010 A1
20100198347 Zakay et al. Aug 2010 A1
20100211166 Miller et al. Aug 2010 A1
20100217382 Chau et al. Aug 2010 A1
20100234935 Bashiri et al. Sep 2010 A1
20100249915 Zhang Sep 2010 A1
20100249920 Bolling et al. Sep 2010 A1
20100262232 Annest Oct 2010 A1
20100262233 He Oct 2010 A1
20100280603 Maisano et al. Nov 2010 A1
20100280604 Zipory et al. Nov 2010 A1
20100280605 Hammer et al. Nov 2010 A1
20100286628 Gross Nov 2010 A1
20100286767 Zipory et al. Nov 2010 A1
20100305475 Hinchliffe et al. Dec 2010 A1
20100324598 Anderson Dec 2010 A1
20110004298 Lee et al. Jan 2011 A1
20110011917 Loulmet Jan 2011 A1
20110029066 Gilad et al. Feb 2011 A1
20110066231 Cartledge et al. Mar 2011 A1
20110071626 Wright et al. Mar 2011 A1
20110082538 Dahlgren et al. Apr 2011 A1
20110087146 Ryan et al. Apr 2011 A1
20110093002 Rucker et al. Apr 2011 A1
20110106245 Miller et al. May 2011 A1
20110106247 Miller et al. May 2011 A1
20110118832 Punjabi May 2011 A1
20110137410 Hacohen Jun 2011 A1
20110166649 Gross et al. Jul 2011 A1
20110184510 Maisano et al. Jul 2011 A1
20110190879 Bobo et al. Aug 2011 A1
20110202130 Cartledge et al. Aug 2011 A1
20110208283 Rust Aug 2011 A1
20110224785 Hacohen Sep 2011 A1
20110230961 Langer et al. Sep 2011 A1
20110238088 Bolduc et al. Sep 2011 A1
20110257633 Cartledge et al. Oct 2011 A1
20110257728 Kuehn Oct 2011 A1
20110264208 Duffy et al. Oct 2011 A1
20110276062 Bolduc Nov 2011 A1
20110282361 Miller et al. Nov 2011 A1
20110288635 Miller Nov 2011 A1
20110301698 Miller et al. Dec 2011 A1
20120022557 Cabiri et al. Jan 2012 A1
20120022639 Hacohen et al. Jan 2012 A1
20120022640 Gross et al. Jan 2012 A1
20120022644 Reich et al. Jan 2012 A1
20120035712 Maisano et al. Feb 2012 A1
20120078355 Zipory et al. Mar 2012 A1
20120078359 Li et al. Mar 2012 A1
20120089022 House et al. Apr 2012 A1
20120095552 Spence et al. Apr 2012 A1
20120109155 Robinson et al. May 2012 A1
20120123531 Tsukashima et al. May 2012 A1
20120136436 Cabiri et al. May 2012 A1
20120143323 Hasenkam et al. Jun 2012 A1
20120150290 Gabbay Jun 2012 A1
20120158021 Morrill Jun 2012 A1
20120191182 Hauser et al. Jul 2012 A1
20120197388 Khairkhahan et al. Aug 2012 A1
20120226349 Tuval et al. Sep 2012 A1
20120239142 Liu et al. Sep 2012 A1
20120245604 Tegzes Sep 2012 A1
20120271198 Whittaker Oct 2012 A1
20120283757 Miller et al. Nov 2012 A1
20120296417 Hill et al. Nov 2012 A1
20120296419 Richardson et al. Nov 2012 A1
20120310330 Buchbinder et al. Dec 2012 A1
20120323313 Seguin Dec 2012 A1
20120330410 Hammer et al. Dec 2012 A1
20120330411 Gross et al. Dec 2012 A1
20130023758 Fabro Jan 2013 A1
20130035759 Gross et al. Feb 2013 A1
20130079873 Migliazza et al. Mar 2013 A1
20130090724 Subramanian et al. Apr 2013 A1
20130096672 Reich et al. Apr 2013 A1
20130096673 Hill et al. Apr 2013 A1
20130116776 Gross et al. May 2013 A1
20130116780 Miller et al. May 2013 A1
20130123910 Cartledge et al. May 2013 A1
20130131791 Hlavka et al. May 2013 A1
20130131792 Miller et al. May 2013 A1
20130172992 Gross et al. Jul 2013 A1
20130190863 Call et al. Jul 2013 A1
20130190866 Zipory et al. Jul 2013 A1
20130197632 Kovach et al. Aug 2013 A1
20130204361 Adams et al. Aug 2013 A1
20130226289 Shaolian et al. Aug 2013 A1
20130226290 Yellin et al. Aug 2013 A1
20130268069 Zakay et al. Oct 2013 A1
20130289718 Tsukashima et al. Oct 2013 A1
20130304093 Serina et al. Nov 2013 A1
20140018914 Zipory et al. Jan 2014 A1
20140088368 Park Mar 2014 A1
20140094826 Sutherland et al. Apr 2014 A1
20140094903 Miller et al. Apr 2014 A1
20140094906 Spence et al. Apr 2014 A1
20140135799 Henderson May 2014 A1
20140142619 Serina et al. May 2014 A1
20140142695 Gross et al. May 2014 A1
20140148849 Serina et al. May 2014 A1
20140148898 Gross et al. May 2014 A1
20140155783 Starksen et al. Jun 2014 A1
20140163670 Alon et al. Jun 2014 A1
20140163690 White Jun 2014 A1
20140188108 Goodine et al. Jul 2014 A1
20140188140 Meier et al. Jul 2014 A1
20140188215 Hlavka et al. Jul 2014 A1
20140194976 Starksen et al. Jul 2014 A1
20140207231 Hacohen et al. Jul 2014 A1
20140222137 Miller et al. Aug 2014 A1
20140243859 Robinson Aug 2014 A1
20140243894 Groothuis et al. Aug 2014 A1
20140243963 Sheps et al. Aug 2014 A1
20140257475 Gross et al. Sep 2014 A1
20140275757 Goodwin et al. Sep 2014 A1
20140276648 Hammer et al. Sep 2014 A1
20140303649 Nguyen et al. Oct 2014 A1
20140303720 Sugimoto et al. Oct 2014 A1
20140309661 Sheps et al. Oct 2014 A1
20140309730 Alon et al. Oct 2014 A1
20140324164 Gross et al. Oct 2014 A1
20140343668 Zipory et al. Nov 2014 A1
20140379006 Sutherland et al. Dec 2014 A1
20150012087 Miller et al. Jan 2015 A1
20150018940 Quill et al. Jan 2015 A1
20150051697 Spence et al. Feb 2015 A1
20150127097 Neumann et al. May 2015 A1
20150272734 Sheps et al. Oct 2015 A1
20150351906 Hammer et al. Dec 2015 A1
Foreign Referenced Citations (85)
Number Date Country
0611561 Aug 1994 EP
0614342 Sep 1994 EP
1006905 Jun 2000 EP
0954257 Aug 2000 EP
1258437 Nov 2002 EP
0871417 Oct 2003 EP
1266641 Oct 2004 EP
1034753 Feb 2005 EP
1562522 Dec 2008 EP
1258232 Jan 2009 EP
1420723 Jan 2009 EP
1903991 Sep 2009 EP
1418865 Oct 2009 EP
1531762 Apr 2010 EP
2273928 Jan 2011 EP
1450733 Feb 2011 EP
2445417 May 2012 EP
11792047.0 Oct 2012 EP
1861045 Mar 2015 EP
1465555 May 2015 EP
223448 Dec 2012 IL
1992005093 Apr 1992 WO
1993010714 Jun 1993 WO
1996039963 Dec 1996 WO
1996040344 Dec 1996 WO
1997001369 Jan 1997 WO
1998046149 Oct 1998 WO
1999030647 Jun 1999 WO
2000009048 Feb 2000 WO
2000022981 Apr 2000 WO
2001026586 Apr 2001 WO
2001056457 Aug 2001 WO
2002085250 Oct 2002 WO
2002085251 Oct 2002 WO
2002085252 Oct 2002 WO
03028558 Apr 2003 WO
2003047467 Jun 2003 WO
2003049647 Jun 2003 WO
03105667 Dec 2003 WO
2004103434 Dec 2004 WO
2005021063 Mar 2005 WO
2005046488 May 2005 WO
2005062931 Jul 2005 WO
2006012013 Feb 2006 WO
2006012038 Feb 2006 WO
2006086434 Aug 2006 WO
2006097931 Sep 2006 WO
2006105084 Oct 2006 WO
2006116558 Nov 2006 WO
2007011799 Jan 2007 WO
2007136783 Nov 2007 WO
2008014144 Jan 2008 WO
2008031103 Mar 2008 WO
2008068756 Jun 2008 WO
2009130631 Oct 2009 WO
2010004546 Jan 2010 WO
2010006905 Jan 2010 WO
10044851 Apr 2010 WO
2010065274 Jun 2010 WO
2010073246 Jul 2010 WO
2010085649 Jul 2010 WO
2010128502 Nov 2010 WO
2010128503 Nov 2010 WO
2010150178 Dec 2010 WO
2011051942 May 2011 WO
2011067770 Jun 2011 WO
2011089601 Jul 2011 WO
2011111047 Sep 2011 WO
2011148374 Dec 2011 WO
2011154942 Dec 2011 WO
2012011108 Jan 2012 WO
2012014201 Feb 2012 WO
2012068541 May 2012 WO
2012176195 Dec 2012 WO
2013021374 Feb 2013 WO
2013021375 Feb 2013 WO
2013069019 May 2013 WO
2013088327 Jun 2013 WO
2014064694 May 2014 WO
2014064695 May 2014 WO
2014076696 May 2014 WO
2014087402 Jun 2014 WO
2014115149 Jul 2014 WO
2014195786 Dec 2014 WO
2016087934 Jun 2016 WO
Non-Patent Literature Citations (213)
Entry
An English Translation of an Office Action dated Nov. 24, 2015, which issued during the prosecution of Israel Patent Application No. 223448. (the relevant part only).
An Office Action dated Oct. 5, 2015, which issued during the prosecution of U.S. Appl. No. 14/246,417.
An Office Action dated Oct. 1, 2015, which issued during the prosecution of U.S. Appl. No. 14/141,228.
European Search Report dated Sep. 25, 2015 which issued during the prosecution of Applicant's European App No. 09794095.1.
European Search Report dated Nov. 4, 2015 which issued during the prosecution of Applicant's European App No. 10772091.4.
European Search Report dated Nov. 16, 2015 which issued during the prosecution of Applicant's European App No. 10826224.7.
An Office Action dated Jan. 4, 2016, which issued during the prosecution of U.S. Appl. No. 14/589,100.
An Office Action dated Jan. 6, 2016, which issued during the prosecution of U.S. Appl. No. 14/128,756.
An International Search Report and a Written Opinion both dated Jan. 25, 2016, which issued during the prosecution of Applicant's PCT/IL2015/051027.
An Office Action dated Jan. 5, 2016, which issued during the prosecution of U.S. Appl. No. 14/084,426.
An Office Action dated Jan. 5, 2016, which issued during the prosecution of U.S. Appl. No. 14/027,934.
An Office Action dated Jul. 30, 2015, which issued during the prosecution of U.S. Appl. No. 13/319,007.
An Office Action dated Aug. 7, 2015, which issued during the prosecution of U.S. Appl. No. 14/128,756.
An English translation of an Office Action dated Jul. 17, 2015 which issued during the prosecution of Chinese Patent Application No. 201080059948.4.
An Office Action dated Jun. 18, 2015, which issued during the prosecution of U.S. Appl. No. 14/551,951.
An Office Action dated Jun. 18, 2015, which issued during the prosecution of U.S. Appl. No. 13/319,030.
An Office Action dated Jun. 11, 2015, which issued during the prosecution of European Patent Application No. 11811934.6.
An International Search Report and a Written Opinion both dated May 12, 2015, which issued during the prosecution of Applicant's PCT/IL2014/050914.
European Search Report dated Apr. 29, 2015, which issued during the prosecution of Applicant's European App No. 14200202.
A Chinese Office Action dated Dec. 12, 2013 in CN Application No. 200980157331.3.
A Notice of Allowance dated Apr. 3, 2013, which issued during the prosecution of U.S. Appl. No. 12/563,930.
A Notice of Allowance dated Apr. 27, 2012, which issued during the prosecution of U.S. Appl. No. 12/341,960.
A Notice of Allowance dated Jan. 7, 2014, which issued during the prosecution of U.S. Appl. No. 12/926,673.
A Notice of Allowance dated Jun. 26, 2012, which issued during the prosecution of U.S. Appl. No. 12/608,316.
A Notice of Allowance dated May 2, 2013, which issued during the prosecution of U.S. Appl. No. 12/843,412.
A Notice of Allowance dated May 22, 2013, which issued during the prosecution of U.S. Appl. No. 12/689,635.
A Notice of Allowance dated May 24, 2012, which issued during the prosecution of U.S. Appl. No. 12/563,952.
A Notice of Allowance dated Sep. 18, 2012, which issued during the prosecution of U.S. Appl. No. 12/706,868.
A Restriction Requirement dated Apr. 1, 2011, which issued during the prosecution of U.S. Appl. No. 12/608,316.
A Restriction Requirement dated Apr. 19, 2010, which issued during the prosecution of U.S. Appl. No. 12/341,960.
A Restriction Requirement dated Feb. 4, 2013, which issued during the prosecution of U.S. Appl. No. 13/141,606.
A Restriction Requirement dated Jan. 6, 2012, which issued during the prosecution of U.S. Appl. No. 12/795,026.
A Restriction Requirement dated Jul. 5, 2012, which issued during the prosecution of U.S. Appl. No. 12/563,930.
A Restriction Requirement dated Jul. 12, 2011, which issued during the prosecution of U.S. Appl. No. 12/437,103.
A Restriction Requirement dated Mar. 30, 2012, which issued during the prosecution of U.S. Appl. No. 12/785,717.
A Restriction Requirement dated May 1, 2012, which issued during the prosecution of U.S. Appl. No. 12/843,412.
A Restriction Requirement dated Nov. 19, 2012, which issued during the prosecution of U.S. Appl. No. 12/926,673.
A Restriction Requirement dated Nov. 2, 2012, which issued during the prosecution of U.S. Appl. No. 13/167,492.
A Restriction Requirement dated Nov. 14, 2011 which issued during the prosecution of U.S. Appl. No. 12/548,991.
A Restriction Requirement dated Oct. 25, 2012 which issued during the prosecution of U.S. Appl. No. 13/167,444.
A Restriction Requirement dated Sep. 14, 2012, which issued during the prosecution of U.S. Appl. No. 12/795,192.
Communication dated Feb. 1, 2011, which issued during the prosecution of Applicant's European Patent Application No. EP 07849540.
A Supplementary European Search Report dated Dec. 4, 2012, which issued during the prosecution of European Patent Application No. EP 09834225.6.
Agarwal et al International Cardiology Perspective Functional Tricuspid Regurgitation, Circ Cardiovasc Interv 2009;2;2;565-573 (2009).
Alfieri et al “Novel Suture Device for Beating-Heart Mitral Leaflet Approximation”, Ann Thorac Surg 2002, 74:1488-1493.
Alfieri et al, “An effective technique to correct anterior mitrel leaflet prolapse,” J Card Surg 14(6):468-470 (1999).
A Supplementary European Search Report dated Mar. 28, 2013, which issued during the prosecution of European Patent Application No. EP 10772091.4.
Alfieri et al, “The double orifice technique in mitrel valve repair: a simple solution for complex problems,” Journal of Thoracic Cardiovascular Surgery 122:674-681 (2001).
Alfieri et al, “The edge to edge technique,” The European Association for Cardia-Thoracic Surgery 14th Annual Meeting Oct. 7-11, Book of Process (2000).
Alfieri, “The edge-to-edge repair of the mitral valve,” Abstract 6th Annual New Era Cardiac Care: Innovation & Technology, Heart Surgery Forum pp. 103 (2003).
Amplatzer Cardiac Plug brochure (English pages), AGA Medical Corporation (Plymouth, MN) (copyright 2008-2010, downloaded Jan. 11, 2011).
Amplatzer Cribriform Occluder A Patient's Guide to Percutaneous, Transcatheter, Atrial Septal Defect Closure AGA Medical Corporation, Apr. 2008.
Amplatzer Septal Occluder A patient guide to the Non-Surgical Closure of the Atrial Septal Defect Using the Amplatzer Septal Occluder System, AGA Medical Corporation, 0412008.
An Advisory Action dated Sep. 6, 2012 which issued during the prosecution of U.S. Appl. No. 12/548,991.
An English translation of an Office Action dated Apr. 23, 2014 which issued during the prosecution of Chinese Patent Application No. 201080059948.4.
An English translation of an office Action dated Jul. 25, 2014 which issued during the prosecution of Chinese Patent Application No. 200980157331.3.
An International Preliminary Report on Patentability dated Nov. 9, 2011, which issued during the prosecution of Applicant's PCT/IL2010/000357.
An International Preliminary Report on Patentability dated Dec. 18, 2010, which issued during the prosecution of Applicant's PCT/IL09/00593.
An International Preliminary Report on Patentability dated Dec. 23, 2014, which issued during the prosecution of Applicant's PCT/IL2012/050451.
U.S. Appl. No. 61/733,979, filed Dec. 6, 2012.
U.S. Appl. No. 61/820,979, filed May 8, 2013.
An International Preliminary Report on Patentability dated Feb. 4, 2014, which issued during the prosecution of Applicant's PCT/IL2011/000446.
An International Preliminary Report on Patentability dated Jan. 29, 2013, which issued during the prosecution of Applicant's PCT/IL20 1 1/000600.
An International Preliminary Report on Patentability dated Jun. 29, 2011, which issued during the prosecution of Applicant's PCT/IL2009/001209.
An International Preliminary Report on Patentability dated Jun. 5, 2012, which issued during the prosecution of Applicant's PCT/IL2010/001024.
An International Preliminary Report on Patentability dated May 1, 2012, which issued during the prosecution of Applicant's PCT/IL2010/000890.
An International Preliminary Report on Patentability dated Nov. 9, 2011 which issued during the prosecution of Applicant's PCT/IL2010/000358.
An International Preliminary Report on Patentability dated Nov. 27, 2012, which issued during the prosecution of Applicant's PCT/IL2011/000404.
An International Search Report and a Written opinion both dated Aug. 17, 2010, which issued during the prosecution of Applicant's PCT/IL10/00357.
An International Search Report and a Written opinion both dated Feb. 22, 2013, which issued during the prosecution of Applicant's PCT/IL2012/50451.
An International Search Report and a Written opinion both dated Feb. 10, 2011, which issued during the prosecution of Applicant's PCT/IL2010/000890.
An International Search Report and a Written opinion both dated Dec. 6, 2012, which issued during the prosecution of Applicant's PCT/IL2012/000250.
An International Search Report and a Written opinion both dated Nov. 8, 2010, which issued during the prosecution of Applicant's PCT/IL2010/000358.
An International Search Report and a Written Opinion both dated Nov. 14, 2011, which issued during the prosecution of Applicant's PCT/IL2011/000404.
An International Search Report and a Written opinion both dated Nov. 23, 2011, which issued during the prosecution of Applicant's PCT/IL2011/000446.
An International Search Report and a Written opinion both dated Apr. 9, 2014, which issued during the prosecution of Applicant's PCT/IL2013/050860.
An International Search Report dated Feb. 2, 2012, which issued during the prosecution of Applicant's PCT/IL2011/000600.
An International Search Report dated Jun. 10, 2010, which issued during the prosecution of Applicant's PCT/IL09/01209.
An International Search Report dated May 19, 2011, which issued during the prosecution of Applicant's PCT/IL2011/00064.
An International Search Report dated Sep. 8, 2009, which issued during the prosecution of Applicant's PCT/IL09/00593.
An International Search Report together with Written opinion both dated Mar. 30, 2011, which issued during the prosecution of Applicant's PCT/IL2010/001024.
An Interview Summary dated Jul. 27, 2011, which issued during the prosecution of U.S. Appl. No. 12/341,960.
An Notice of Allowance dated Dec. 7, 2011, which issued during the prosecution of U.S. Appl. No. 12/435,291.
An office Action dated Apr. 2, 2013, which issued during the prosecution of U.S. Appl. No. 12/785,717.
An office Action dated Aug. 13, 2012, which issued during the prosecution of U.S. Appl. No. 13/044,694.
An office Action dated Aug. 24, 2012, which issued during the prosecution of U.S. Appl. No. 12/563,930.
An office Action dated Dec. 31, 2012, which issued during the prosecution of U.S. Appl. No. 13/044,694.
An office Action dated Feb. 14, 2013, which issued during the prosecution of U.S. Appl. No. 13/167,492.
An office Action dated Jan. 17, 2013, which issued during the prosecution of U.S. Appl. No. 13/167,444.
An office Action dated Jul. 18, 2013, which issued during the prosecution of U.S. Appl. No. 13/044,694.
An office Action dated Jul. 20, 2012, which issued during the prosecution of U.S. Appl. No. 12/843,412.
An office Action dated Apr. 1, 2013, which issued during the prosecution of Patent Application No. 13/167,476.
An office Action dated Feb. 12, 2013, which issued during the prosecution of U.S. Appl. No. 12/926,673.
An office Action dated Feb. 3, 2014 which issued during the prosecution of U.S. Appl. No. 12/689,693.
An office Action dated Jun. 11, 2014, which issued during the prosecution of U.S. Appl. No. 14/027,934.
An office Action dated Jun. 4, 2014, which issued during the prosecution of U.S. Appl. No. 12/840,463.
An office Action dated Jun. 7, 2013, which issued during the prosecution of U.S. Appl. No. 13/141,606.
An office Action dated Mar. 9, 2012, which issued during the prosecution of U.S. Appl. No. 12/689,635.
An office Action dated Mar. 27, 2013, which issued during the prosecution of U.S. Appl. No. 12/843,412.
An office Action dated Mar. 29, 2011, which issued during the prosecution of U.S. Appl. No. 12/341,960.
An office Action dated May 6, 2013, which issued during the prosecution of U.S. Appl. No. 12/689,693.
An office Action dated May 10, 2012, which issued during the prosecution of U.S. Appl. No. 12/795,026.
An office Action dated Apr. 6, 2010, which issued during the prosecution of Applicant's U.S. Appl. No. 12/484,512.
An office Action dated Aug. 4, 2010, which issued during the prosecution of U.S. Appl. No. 12/341,960.
An office Action dated Aug. 15, 2013, which issued during the prosecution of U.S. Appl. No. 12/795,192.
An office Action dated Aug. 2, 2011 which issued during the prosecution of U.S. Appl. No. 12/435,291.
An office Action dated Aug. 23, 2013, which issued during the prosecution of U.S. Appl. No. 13/167,444.
An office Action dated Aug. 5, 2010 which issued during the prosecution of U.S. Appl. No. 11/950,930.
An Office Action dated Aug. 6, 2012, which issued during the prosecution of U.S. Appl. No. 12/548,991.
An office Action dated Dec. 18, 2013, which issued during the prosecution of U.S. Appl. No. 13/666,141.
An office Action dated Dec. 29, 2011, which issued during the prosecution of U.S. Appl. No. 12/563,952.
An office Action dated Jan. 23, 2012, which issued during the prosecution of U.S. Appl. No. 12/692,061.
An office Action dated Jan. 27, 2012, which issued during the prosecution of U.S. Appl. No. 12/548,991.
An office Action dated Feb. 17, 2010 which issued during the prosecution of U.S. Appl. No. 11/950,930.
An office Action dated Jan. 17, 2013, which issued during the prosecution of U.S. Appl. No. 12/795,192.
An office Action dated Jul. 6, 2012, which issued during the prosecution of U.S. Appl. No. 12/692,061.
An office Action dated Jun. 10, 2014, which issued during the prosecution of U.S. Appl. No. 13/167,492.
An office Action dated Jun. 13, 2012, which issued during the prosecution of U.S. Appl. No. 12/437,103.
An office Action dated May 5, 2011, which issued during the prosecution of U.S. Appl. No. 12/706,868.
An office Action dated May 19, 2011, which issued during the prosecution of U.S. Appl. No. 12/706,868.
An office Action dated May 30, 2012, which issued during the prosecution of U.S. Appl. No. 12/706,868.
An office Action dated Nov. 5, 2012, which issued during the prosecution of U.S. Appl. No. 12/795,026.
An office Action dated Nov. 14, 2011, which issued during the prosecution of U.S. Appl. No. 12/608,316.
An Office Action dated Nov. 21, 2013, which issued during the prosecution of U.S. Appl. No. 13/167,476.
An office Action dated Nov. 30, 2012, which issued during the prosecution of U.S. Appl. No. 12/689,635.
An office Action dated Oct. 3, 2014, which issued during the prosecution of U.S. Appl. No. 13/749,153.
An office Action dated Oct. 22, 2013, which issued during the prosecution of U.S. Appl. No. 12/926,673.
An office Action dated Oct. 27, 2011, which issued during the prosecution of U.S. Appl. No. 12/563,952.
An office Action dated Jun. 2, 2014, which issued during the prosecution of U.S. Appl. No. 13/319,030.
An office Action dated Oct. 2, 2013, which issued during the prosecution of U.S. Appl. No. 13/167,492.
An office Action dated Sep. 28, 2011, which issued during the prosecution of U.S. Appl. No. 12/437,103.
An office Action dated Oct. 6, 2010, which issued during the prosecution of Applicant's U.S. Appl. No. 12/484,512.
An office Action dated Oct. 9, 2013, which issued during the prosecution of U.S. Appl. No. 12/996,954.
An office Action dated Sep. 1, 2011, which issued during the prosecution of U.S. Appl. No. 12/706,868.
An office Action dated Sep. 16, 2009 which issued during the prosecution of U.S. Appl. No. 11/950,930.
Communication dated Aug. 22, 2014 from the United States Patent and Trademark Office in counterpart U.S. Appl. No. 14/027,934.
Communication dated Aug. 26, 2014 from the United States Patent and Trademark Office in counterpart U.S. Appl. No. 13/167,444.
Dang NC et al “Simplified Placement of Multiple Artificial Mitral Valve Chords,” The Heart Surgery Forum #2005-1005 8 (3) (2005).
Dictionary.com definition of “lock”, Jul. 29, 2013.
Dieter RS, “Percutaneous valve repair: Update on mitral regurgitation and endovascular approaches to the mitral valve,” Applications in Imaging, Cardiac Interventions, Supported by an educational grant from Amersham Health pp. 11-14 (2003).
Langer et al Ring plus String: Papillary muscle repositioning as an adjunctive repair technique for ischemic mitral regurgitation, The Journal of Thoracic Cardiovascular surgery vol. 133 No. 1, Jan. 2007.
Notice of Allowance dated Jun. 11, 2014, which issued during the prosecution of U.S. Appl. No. 12/689,693.
Notice of Allowance dated Jun. 23, 2014, which issued during the prosecution of U.S. Appl. No. 12/548,991.
Notice of Allowance dated Jun. 25, 2014, which issued during the prosecution of U.S. Appl. No. 13/666,262.
Notice of Allowance dated Mar. 6, 2014, which issued during the prosecution of U.S. Appl. No. 12/437,103.
Notice of Allowance dated Nov. 19, 2013, which issued during the prosecution of U.S. Appl. No. 12/795,192.
Communication dated Oct. 14, 2014 from the United States Patent and Trademark Office in counterpart application No. 13/319,030.
An office Action dated Sep. 29, 2014, which issued during the prosecution of U.S. Appl. No. 13/504,870.
Communication regarding amended claims filed dated Dec. 27, 2012, regarding European Application No. 11792047.0.
Langer et al RING+STRING, Successful Repair technique for ischemic mitral regurgitation with severe leaflet Tethering, The Department of Thoracic Cardiovascular surgery, Hamburg, Germany, Nov. 2008.
Maisano, The double-orifice technique as a standardized approach to treat mitral . . . , European Journal of Cardio-thoracic Surgery 17 (2000) 201-205.
Odell JA et al., “Early Results of a Simplified Method of Mitral Valve Annuloplasty,” Circulation 92:150-154 (1995).
Office Action dated Dec. 16, 2013 in U.S. Appl. No. 13/666,262.
Supplementary European Search Report dated Oct. 23, 2014 which issued during the prosecution of Applicant's European App No. 10826224.7.
Supplementary European Search Report dated Jan. 21, 2014 which issued during the prosecution of Applicant's European App No. 11 78 6226.
Swain CP et al., “An endoscopically deliverable tissue-transfixing device for securing biosensors in the gastrointestinal tract,” Gastrointestinal Endoscopy 40(6): 730-734 (1994).
Two dimensional real-time ultrasonic imaging of the heart and great vessels, Mayo Clin Proc vol. 53:271-303, 1978.
U.S. Appl. No. 60/902,146, filed Feb. 16, 2007.
U.S. Appl. No. 61/001,013, filed Oct. 29, 2007.
U.S. Appl. No. 61/745,848, filed Dec. 6, 2012.
U.S. Final Office Action dated Dec. 27, 2013, issued in corresponding U.S. Appl. No. 12/785,717.
O'Reilly S et al., “Heart valve surgery pushes the envelope,” Medtech Insight 8(3): 73, 99-108 (2006).
Restriction Requirement dated Nov. 14, 2011, which issued during the prosecution of U.S. Appl. No. 12/689,635.
Office Action dated Dec. 19, 2013 in U.S. Appl. No. 14/027,934.
Search Report in European Patent Application 107720906 dated Jan. 17, 2014.
U.S. Appl. No. 60/873,075, filed Dec. 5, 2006.
U.S. Appl. No. 61/132,295, filed Jun. 16, 2008.
U.S. Appl. No. 61/265,936, filed Dec. 2, 2009.
U.S. Appl. No. 61/283,445, filed Dec. 2, 2009.
U.S. Appl. No. 61/555,570, filed Nov. 4, 2011.
U.S. Appl. No. 61/207,908, filed Feb. 17, 2009.
U.S. Appl. No. 61/557,082, filed Nov. 8, 2011.
U.S. Appl. No. 61/717,303, filed Oct. 23, 2012.
An office Action dated Apr. 2, 2015, which issued during the prosecution of U.S. Appl. No. 14/027,934.
An International Search Report and a Written opinion both dated Mar. 21, 2014, which issued during the prosecution of Applicant's PCT/IL2013/050992.
Notice of Allowance dated Feb. 2, 2015, which issued during the prosecution of U.S. Appl. No. 13/504,870.
Notice of Allowance dated Dec. 24, 2014, which issued during the prosecution of U.S. Appl. No. 12/795,026.
Notice of Allowance dated Mar. 24, 2015, which issued during the prosecution of U.S. Appl. No. 14/486,226.
An Office Action dated Mar. 16, 2015, which issued during the prosecution of U.S. Appl. No. 14/084,426.
Notice of Allowance dated Nov. 13, 2014, which issued during the prosecution of U.S. Appl. No. 12/795,026.
Supplementary European Search Report dated Jan. 20, 2015 which issued during the prosecution of Applicant's European App No. 12803037.
Communication dated Jan. 13, 2015, issued by the European Patent Office in corresponding application No. 10834311.2.
Supplementary European Search Report dated Mar. 23, 2015 which issued during the prosecution of Applicant's European App No. 11792047.
Notice of Allowance dated Dec. 20, 2013, which issued during the prosecution of U.S. Appl. No. 12/437,103.
An Office Action dated Jan. 13, 2015, which issued during the prosecution of U.S. Appl. No. 13/707,013.
An Office Action dated Mar. 23, 2015, which issued during the prosecution of U.S. Appl. No. 13/707,013.
U.S. Appl. No. 61/782,121, filed Mar. 14, 2013.
Swenson, O. and Malinin, T.I., 1978: “An improved mechanical device for control of urinary incontinence,” Investigative urology, 15(5), pp. 389-391.
Swenson, O.: “An experimental implantable urinary sphincter,” Invest Urol. Sep. 1976;14(2):100-3.
European Search Report dated Jun. 24, 2016, which issued during the prosecution of European Patent Application No. EP 12847363.
European Search Report dated Jul. 8, 2016, which issued during the prosecution of Applicant's European App No. 13849843.1.
European Search Report dated Jul. 15, 2016, which issued during the prosecution of Applicant's European App No. 13849947.0.
An Office Action dated Jul. 20, 2016, which issued during the prosecution of U.S. Appl. No. 14/246,417.
Daebritz, S., et al. “Experience with an adjustable pulmonary artery banding device in two cases: initial success-midterm failure.” The Thoracic and cardiovascular surgeon 47.01 (1999): 51-52.
Elliott, Daniel S., Gerald W. Timm, and David M. Barrett. “An implantable mechanical urinary sphincter: a new nonhydraulic design concept.” Urology52.6 (1998): 1151-1154.
Park, Sang C., et al. “A percutaneously adjustable device for banding of the pulmonary trunk.” International journal of cardiology 9.4 (1985): 477-484.
Swenson, Orvar. “Internal device for control of urinary incontinence.” Journal of pediatric surgery 7.5 (1972): 542-545.
An Invitation to pay additional fees dated Aug. 18, 2016, which issued during the prosecution of Applicant's PCT/IL2016/050433.
Ahmadi, A., G. Spillner, and Th Johannesson. “Hemodynamic changes following experimental production and correction of acute mitral regurgitation with an adjustable ring prosthesis.” The Thoracic and cardiovascular surgeon36.06 (1988): 313-319.
Ahmadi, Ali, et al. “Percutaneously adjustable pulmonary artery band.” The Annals of thoracic surgery 60 (1995): S520-S522.
Assad, Renato S. “Adjustable Pulmonary Artery Banding.” (2014).
An English Translation of an Office Action dated Sep. 15, 2016, which issued during the prosecution of Israel Patent Application No. 243837. (the relevant part only).
Non Final Office Action dated Oct. 21, 2016, issued by the U.S. Patent and Trademark Office in U.S. Appl. No. 14/567,472.
ISR & Written Opinion dated Oct. 17, 2016, issued in International Application No. PCT/IL2016/050433.
An Office Action dated May 4, 2016, which issued during the prosecution of U.S. Appl. No. 14/589,100.
An Office Action dated Jun. 17, 2016, which issued during the prosecution of U.S. Appl. No. 14/357,040.
An Office Action dated Jun. 14, 2016, which issued during the prosecution of U.S. Appl. No. 14/273,155.
An Office Action dated Apr. 7, 2016, which issued during the prosecution of U.S. Appl. No. 14/242,151.
Notice of Allowance dated May 3, 2016, which issued during the prosecution of U.S. Appl. No. 13/319,030.
An Office Action dated Apr. 8, 2016, which issued during the prosecution of U.S. Appl. No. 14/141,228.
Notice of Allowance dated Apr. 12, 2016, which issued during the prosecution of U.S. Appl. No. 14/667,090.
An Office Action dated May 11, 2016, which issued during the prosecution of U.S. Appl. No. 14/128,756.
Notice of Allowance dated May 6, 2016, which issued during the prosecution of U.S. Appl. No. 14/667,090.
Related Publications (1)
Number Date Country
20140276648 A1 Sep 2014 US
Provisional Applications (1)
Number Date Country
61782121 Mar 2013 US